unit,Term,Adjusted P-value,Overlap,overlap_ratio,Odds Ratio,Combined Score,Genes,n_high,fraction_high
246,Cytokine-Mediated Signaling Pathway (GO:0019221),7.2392444929935e-18,28/255,0.10980392156862745,14.036574121503945,660.9365026540906,CSF1R;CXCL9;CSF2RB;TNFRSF11A;IL2RG;CSF2RA;CCL8;STAT4;IL12B;JAK2;JAK1;IL12RB2;IL13RA1;IL10;IL11;IL33;SMAD4;IFNB1;TNFRSF1B;IL22RA1;IL1A;HCK;CXCL10;CEACAM1;IL1B;XCL1;IL6ST;IL7R,4062,0.050002461962676645
246,Regulation of Tumor Necrosis Factor Production (GO:0032680),9.376226421238097e-11,16/131,0.12213740458015267,14.88468809073724,430.4387352377303,IL10;APP;IL33;FZD5;C5AR2;TWIST1;MMP8;VSIR;IFIH1;IL1A;PTPRC;IL12B;EPHB2;JAK2;TLR4;CD33,4062,0.050002461962676645
246,Response to Cytokine (GO:0034097),4.0858771032543975e-10,15/123,0.12195121951219512,14.783783783783784,401.5068286335162,IFNAR2;APP;CD274;CSF1R;SERPINA3;IFITM1;TNFRSF11A;CASP8;SELL;IL1B;SELENOP;STAT4;CHI3L1;IL6ST;JAK2,4062,0.050002461962676645
246,Positive Regulation of Leukocyte Proliferation (GO:0070665),4.4271665908675167e-10,8/17,0.47058823529411764,91.625,2470.2641304648364,CSF1R;CSF1;GPNMB;IL12B;CSF2RB;JAK2;CSF2RA;PTK2,4062,0.050002461962676645
246,Positive Regulation of Tumor Necrosis Factor Production (GO:0032760),4.1068150417175495e-09,12/82,0.14634146341463414,17.990881458966566,434.6192800626608,IFIH1;APP;IL1A;IL33;PTPRC;FZD5;IL12B;TWIST1;EPHB2;JAK2;MMP8;TLR4,4062,0.050002461962676645
246,Positive Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),5.350369287848554e-09,12/85,0.1411764705882353,17.248907024191197,409.1679727549326,IFIH1;APP;IL1A;IL33;PTPRC;FZD5;IL12B;TWIST1;EPHB2;JAK2;MMP8;TLR4,4062,0.050002461962676645
246,Cellular Response to Lipopolysaccharide (GO:0071222),3.252877561358615e-08,13/125,0.104,12.220397249809016,264.80608315630144,IL10;CD274;CXCL6;CXCL9;CD80;MMP8;TNFRSF1B;CXCL10;HCK;IL1A;IL1B;JAK2;TLR4,4062,0.050002461962676645
246,Regulation of T Cell Proliferation (GO:0042129),5.124726130120205e-08,11/83,0.13253012048192772,15.947089947089948,337.25274730743286,IL10;CD274;PTPRC;GPNMB;CD80;IL1B;IL12B;JAK2;TNFRSF1B;IL6ST;FOXP3,4062,0.050002461962676645
246,Regulation of Type II Interferon Production (GO:0032649),9.03425831908356e-08,11/88,0.125,14.907785336356763,305.716586855594,CD274;FZD5;DDIT3;IL1B;IL12B;XCL1;JAK2;FOXP3;TLR4;VSIR;IL12RB2,4062,0.050002461962676645
246,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),2.3454851636925907e-07,9/55,0.16363636363636364,20.235146824493512,393.6007286626139,IFNAR2;IFNB1;STAT4;IL12B;CSF2RB;JAK2;IL6ST;CSF2RA;JAK1,4062,0.050002461962676645
246,Mammary Gland Epithelium Development (GO:0061180),2.659755917600757e-07,6/15,0.4,68.01030927835052,1310.0878886918515,CSF1R;WNT7B;JAK2;WNT2;WNT3;EPHA2,4062,0.050002461962676645
246,Negative Regulation of T Cell Mediated Immunity (GO:0002710),5.768888661398427e-07,6/17,0.35294117647058826,55.63917525773196,1022.337713540772,CD274;CEACAM1;PTPRC;CD80;XCL1;FOXP3,4062,0.050002461962676645
246,Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),1.0224332102464425e-06,8/47,0.1702127659574468,21.112179487179485,374.7303730596972,IFNAR2;IFNB1;STAT4;IL12B;CSF2RB;JAK2;CSF2RA;JAK1,4062,0.050002461962676645
246,Cellular Response to Transforming Growth Factor Beta Stimulus (GO:0071560),2.5888493759683558e-06,10/98,0.10204081632653061,11.789473684210526,197.7147693321704,ITGB1;JUN;SMAD4;TGFB2;TGFB3;APOA1;XCL1;WNT7A;WNT2;PTK2,4062,0.050002461962676645
246,Positive Regulation of Lymphocyte Proliferation (GO:0050671),3.4690726319230667e-06,9/77,0.11688311688311688,13.673236834000615,224.33895481846685,CD274;PTPRC;CD81;CD80;IL1B;IL12B;EPHB2;JAK2;IL6ST,4062,0.050002461962676645
246,Cellular Response to Interleukin-6 (GO:0071354),3.680323951968032e-06,6/23,0.2608695652173913,35.99090357792601,587.5720698277966,SMAD4;PTGIS;SELPLG;IL6ST;JAK2;JAK1,4062,0.050002461962676645
246,Secondary Palate Development (GO:0062009),4.973209890206671e-06,5/13,0.38461538461538464,63.43589743589744,1013.7704525458294,SMAD4;TGFB2;WNT11;TGFB3;WNT7A,4062,0.050002461962676645
246,Regulation of Interleukin-8 Production (GO:0032677),5.907009563070462e-06,9/83,0.10843373493975904,12.560775435120984,197.79543589447545,IL10;PTPRC;DDIT3;IL1B;C5AR2;CHI3L1;FFAR2;TLR4;CD33,4062,0.050002461962676645
246,Wnt Signaling Pathway (GO:0016055),5.907009563070462e-06,9/83,0.10843373493975904,12.560775435120984,197.79543589447545,WNT11;FZD5;WNT7B;FZD6;SNAI1;WNT7A;CD24;WNT2;WNT3,4062,0.050002461962676645
246,Canonical Wnt Signaling Pathway (GO:0060070),7.68475574772011e-06,8/63,0.12698412698412698,14.958333333333334,229.98870557377373,WNT11;FZD5;WNT7B;FZD6;SNAI1;WNT7A;WNT2;WNT3,4062,0.050002461962676645
246,Negative Regulation of Lymphocyte Proliferation (GO:0050672),7.68475574772011e-06,7/43,0.16279069767441862,19.9119170984456,305.80839613375537,IL10;CD274;TNFRSF13B;GPNMB;CD80;CTLA4;FOXP3,4062,0.050002461962676645
246,Positive Regulation of Production of Molecular Mediator of Immune Response (GO:0002702),7.68475574772011e-06,7/43,0.16279069767441862,19.9119170984456,305.80839613375537,IL10;PTPRC;XCL1;FFAR2;IL2RG;EPHB2;IL13RA1,4062,0.050002461962676645
246,Positive Regulation of T Cell Proliferation (GO:0042102),8.99671945078324e-06,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,CD274;PTPRC;CD80;IL1B;IL12B;JAK2;IL6ST;CD24,4062,0.050002461962676645
246,Negative Regulation of Type II Interferon Production (GO:0032689),9.142808877172972e-06,6/28,0.21428571428571427,27.804123711340207,418.4588512102148,CD274;DDIT3;XCL1;FOXP3;TLR4;VSIR,4062,0.050002461962676645
246,Collagen Fibril Organization (GO:0030199),9.142808877172972e-06,7/45,0.15555555555555556,18.862012544314155,283.5453231814293,TGFB2;BMP1;COL5A1;COL11A1;COL12A1;COL5A2;CYP1B1,4062,0.050002461962676645
246,Regulation of B Cell Proliferation (GO:0030888),9.142808877172972e-06,7/45,0.15555555555555556,18.862012544314155,283.5453231814293,IL10;PTPRC;TNFRSF13B;CD81;CTLA4;ATM;EPHB2,4062,0.050002461962676645
246,Negative Regulation of Cytokine Production Involved in Immune Response (GO:0002719),1.1069056182515068e-05,5/16,0.3125,46.12820512820513,681.9340623795607,IL10;TGFB2;TGFB3;XCL1;FOXP3,4062,0.050002461962676645
246,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.1069056182515068e-05,8/68,0.11764705882352941,13.708333333333334,202.4938064855017,SMAD4;TGFB2;CASP8;TNFRSF10B;BAX;FASLG;JAK2;TNFRSF1B,4062,0.050002461962676645
246,Positive Regulation of Apoptotic Signaling Pathway (GO:2001235),1.3473317279208644e-05,8/70,0.11428571428571428,13.26478494623656,192.9238825153924,APP;TNFRSF12A;IFNB1;DDIT3;TNFSF10;BAX;FASLG;TLR4,4062,0.050002461962676645
246,Positive Regulation of Epithelial to Mesenchymal Transition (GO:0010718),1.4922812396842185e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,SMAD4;TGFB2;TGFB3;IL1B;SNAI1;TWIST1;PTK2,4062,0.050002461962676645
246,Interleukin-12-Mediated Signaling Pathway (GO:0035722),1.7423045595655902e-05,4/8,0.5,101.0,1437.5971916079902,STAT4;IL12B;JAK2;IL12RB2,4062,0.050002461962676645
246,Negative Regulation of T Cell Activation (GO:0050868),1.876163465160783e-05,7/51,0.13725490196078433,16.28497409326425,230.3788363131684,IL10;CD274;GPNMB;IFNB1;CD80;FOXP3;VSIR,4062,0.050002461962676645
246,Positive Regulation of Chemokine Production (GO:0032722),2.6945322541787723e-05,7/54,0.12962962962962962,15.243192591775989,209.54780112784735,APP;CSF1R;IL33;IL1B;TWIST1;FFAR2;TLR4,4062,0.050002461962676645
246,Regulation of Interleukin-17 Production (GO:0032660),2.938845750526093e-05,6/35,0.17142857142857143,21.08531816565944,287.77059905823296,DDIT3;IL12B;JAK2;FOXP3;TLR4;VSIR,4062,0.050002461962676645
246,Regulation of Receptor Signaling Pathway via JAK-STAT (GO:0046425),2.9877568896860896e-05,7/55,0.12727272727272726,14.924870466321243,203.26608191930924,IL10;PTPRC;CYP1B1;VHL;JAK2;IL7R;CSF2RA,4062,0.050002461962676645
246,Peptidyl-Tyrosine Phosphorylation (GO:0018108),4.2648257809092815e-05,7/58,0.1206896551724138,14.044803413593415,186.1137510453516,HCK;CSF1R;ABL1;EPHB2;JAK2;EGFR;PTK2,4062,0.050002461962676645
246,Cellular Response to Interleukin-12 (GO:0071349),4.476784294283963e-05,4/10,0.4,67.3265306122449,885.3932781130271,STAT4;IL12B;JAK2;IL12RB2,4062,0.050002461962676645
246,"Negative Regulation of CD4-positive, Alpha-Beta T Cell Activation (GO:2000515)",4.476784294283963e-05,4/10,0.4,67.3265306122449,885.3932781130271,CD274;XCL1;RUNX3;VSIR,4062,0.050002461962676645
246,Negative Regulation of Interleukin-17 Production (GO:0032700),4.476784294283963e-05,4/10,0.4,67.3265306122449,885.3932781130271,IL12B;FOXP3;TLR4;VSIR,4062,0.050002461962676645
246,Positive Regulation of Immunoglobulin Production (GO:0002639),4.476784294283963e-05,6/38,0.15789473684210525,19.105670103092784,251.0820739334879,IL10;PTPRC;XCL1;IL2RG;EPHB2;IL13RA1,4062,0.050002461962676645
246,Mammary Gland Development (GO:0030879),4.831494773921624e-05,5/22,0.22727272727272727,29.838612368024133,388.9673545532963,TGFB3;WNT7B;JAK2;WNT2;WNT3,4062,0.050002461962676645
246,Positive Regulation of Peptidyl-Tyrosine Phosphorylation (GO:0050731),6.583082025541101e-05,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,IL11;CSF1R;ANGPT4;IL20;CD80;ABL1;JAK2,4062,0.050002461962676645
246,Macrophage Differentiation (GO:0030225),7.276949669009768e-05,5/24,0.20833333333333334,26.695006747638327,335.64237766536246,CSF1R;IL33;CASP8;CSF1;PARP1,4062,0.050002461962676645
246,Cellular Response to Virus (GO:0098586),7.898228040887121e-05,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,IFIH1;IFNAR2;CXCL10;IFNB1;BAX;JAK2;JAK1,4062,0.050002461962676645
246,Regulation of Chemokine Production (GO:0032642),8.38502545916405e-05,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,APP;CSF1R;IL33;SNAI2;FFAR2;TLR4,4062,0.050002461962676645
246,Regulation of miRNA Transcription (GO:1902893),8.496972983850996e-05,7/66,0.10606060606060606,12.135505400895758,150.08231117190402,IL10;APP;JUN;TGFB2;TWIST1;ESR1;EGFR,4062,0.050002461962676645
246,Cellular Response to Low-Density Lipoprotein Particle Stimulus (GO:0071404),8.496972983850996e-05,5/25,0.2,25.35897435897436,313.3915485176811,ITGB1;APP;CD81;LDLR;TLR4,4062,0.050002461962676645
246,Interleukin-6-Mediated Signaling Pathway (GO:0070102),8.839851719785002e-05,4/12,0.3333333333333333,50.48979591836735,621.4783262572987,SMAD4;IL6ST;JAK2;JAK1,4062,0.050002461962676645
246,Response to Molecule of Bacterial Origin (GO:0002237),9.060451614774386e-05,7/67,0.1044776119402985,11.932642487046632,146.35733988559016,IL10;FZD5;IL1B;SELENOP;TNFRSF11A;CD24;TLR4,4062,0.050002461962676645
246,Regulation of T Cell Migration (GO:2000404),0.00010044833105495824,5/26,0.19230769230769232,24.15018315018315,293.4914392101124,APP;CXCL10;CCL20;APOD;CD69,4062,0.050002461962676645
246,Regulation of Nitric Oxide Biosynthetic Process (GO:0045428),0.00010209415860401932,6/45,0.13333333333333333,15.670896114195084,189.8997840048912,APP;PTGIS;IL1B;JAK2;ESR1;TLR4,4062,0.050002461962676645
246,Regulation of Interleukin-10 Production (GO:0032653),0.000112822320676332,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,CD274;IL12B;XCL1;FOXP3;TLR4;VSIR,4062,0.050002461962676645
246,Mononuclear Cell Differentiation (GO:1903131),0.000112822320676332,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,CSF1R;IL33;CASP8;CSF1;PARP1;IL2RG,4062,0.050002461962676645
246,Peptidyl-Tyrosine Modification (GO:0018212),0.000112822320676332,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,CSF1R;HCK;ABL1;EPHB2;EGFR;PTK2,4062,0.050002461962676645
246,Positive Regulation of Vascular Endothelial Growth Factor Production (GO:0010575),0.00011477158374763242,5/27,0.18518518518518517,23.05128205128205,275.60325810758144,IL1A;IL1B;CYP1B1;BRCA1;IL6ST,4062,0.050002461962676645
246,Regulation of Vascular Endothelial Growth Factor Production (GO:0010574),0.00016324633885385004,5/29,0.1724137931034483,21.128205128205128,244.79950290336265,IL1A;IL1B;CYP1B1;BRCA1;IL6ST,4062,0.050002461962676645
246,Regulation of Interleukin-2 Production (GO:0032663),0.00017502477737075164,6/50,0.12,13.88659793814433,159.57344828850043,IL1A;PTPRC;CD80;IL1B;XCL1;FOXP3,4062,0.050002461962676645
246,Negative Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),0.00017502477737075164,6/50,0.12,13.88659793814433,159.57344828850043,IL10;CD274;C5AR2;TLR4;VSIR;CD33,4062,0.050002461962676645
246,Positive Regulation of Alpha-Beta T Cell Proliferation (GO:0046641),0.00020296477841288572,4/15,0.26666666666666666,36.71428571428572,415.5389408534144,CD81;IL12B;XCL1;JAK2,4062,0.050002461962676645
246,Intrinsic Apoptotic Signaling Pathway in Response to DNA Damage (GO:0008630),0.00021337142131679437,6/52,0.11538461538461539,13.281488121918422,149.54976885226935,CHEK2;BAX;ATM;BRCA1;TNFRSF1B;EPHA2,4062,0.050002461962676645
246,Regulation of Immunoglobulin Production (GO:0002637),0.00021497962047411877,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,IL10;PTPRC;IL2RG;EPHB2;IL13RA1,4062,0.050002461962676645
246,Extrinsic Apoptotic Signaling Pathway via Death Domain Receptors (GO:0008625),0.0002507091419653688,5/32,0.15625,18.77777777777778,208.10711759419505,CASP8;TNFSF10;TNFRSF10B;BAX;FASLG,4062,0.050002461962676645
246,Negative Regulation of Interleukin-10 Production (GO:0032693),0.0002599812211251745,4/16,0.25,33.6530612244898,371.4740483715657,CD274;IL12B;FOXP3;VSIR,4062,0.050002461962676645
246,Interferon-Mediated Signaling Pathway (GO:0140888),0.00028400243264647973,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,IFNAR2;HCK;IFITM1;IFNB1;JAK2;JAK1,4062,0.050002461962676645
246,B Cell Receptor Signaling Pathway (GO:0050853),0.00028400243264647973,5/33,0.15151515151515152,18.106227106227102,197.83659620108145,ITK;PTPRC;CTLA4;BAX;MS4A1,4062,0.050002461962676645
246,Regulation of Cell Adhesion Mediated by Integrin (GO:0033628),0.00028400243264647973,5/33,0.15151515151515152,18.106227106227102,197.83659620108145,TGFB2;CYP1B1;SNAI2;PTK2;EPHA2,4062,0.050002461962676645
246,Positive Regulation of Leukocyte Chemotaxis (GO:0002690),0.0003090827650127968,6/56,0.10714285714285714,12.216494845360824,132.26100624841683,APP;CSF1R;CXCL10;CSF1;XCL1;PTK2,4062,0.050002461962676645
246,B Cell Proliferation (GO:0042100),0.0003179539755330834,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,IL10;PTPRC;IFNB1;MS4A1,4062,0.050002461962676645
246,Leukocyte Tethering or Rolling (GO:0050901),0.0003179539755330834,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,ITGB1;SELPLG;SELL;SELENOP,4062,0.050002461962676645
246,"Regulation of DNA Damage Response, Signal Transduction by P53 Class Mediator (GO:0043516)",0.0003179539755330834,5/34,0.14705882352941177,17.480990274093724,188.3662067044033,SNAI1;TWIST1;SNAI2;ATM;PLA2R1,4062,0.050002461962676645
246,Response to Transforming Growth Factor Beta (GO:0071559),0.0003623704221843053,5/35,0.14285714285714285,16.897435897435898,179.61044178472525,SMAD4;WNT7A;XCL1;WNT2;RUNX3,4062,0.050002461962676645
246,Positive Regulation of Type II Interferon Production (GO:0032729),0.0003623704221843053,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,FZD5;IL1B;IL12B;JAK2;TLR4;IL12RB2,4062,0.050002461962676645
246,Negative Regulation of Smooth Muscle Cell Proliferation (GO:0048662),0.000402802692417086,5/36,0.1388888888888889,16.351530190239867,171.49530707153963,IL10;TGFB3;TPM1;IL12B;APOD,4062,0.050002461962676645
246,Response to Retinoic Acid (GO:0032526),0.0004253227272195572,6/60,0.1,11.309278350515465,117.91686334351428,WNT11;WNT7B;HSD17B2;ATM;WNT2;WNT3,4062,0.050002461962676645
246,Leukocyte Adhesion to Vascular Endothelial Cell (GO:0061756),0.00047046926123195295,4/19,0.21052631578947367,26.918367346938776,277.4179092680899,ITGB1;SELPLG;SELL;SELENOP,4062,0.050002461962676645
246,Regulation of Leukocyte Proliferation (GO:0070663),0.00047046926123195295,3/7,0.42857142857142855,75.36548223350253,776.6239908457204,CSF2RB;JAK2;CSF2RA,4062,0.050002461962676645
246,Lens Fiber Cell Development (GO:0070307),0.00047046926123195295,3/7,0.42857142857142855,75.36548223350253,776.6239908457204,WNT7B;WNT7A;EPHA2,4062,0.050002461962676645
346,Regulation of Tumor Necrosis Factor Production (GO:0032680),1.1051870987529111e-08,14/131,0.10687022900763359,12.662531017369728,299.00106479140754,SYK;IFNGR1;GSTP1;STAT3;NR1H4;TWIST1;HSPB1;AZU1;IFIH1;RARA;LGALS9;JAK2;TLR2;PF4,4062,0.050002461962676645
346,Negative Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001237),2.4547809947496876e-08,11/72,0.1527777777777778,18.833289964437505,428.04343929274273,LGALS3;SRC;GSTP1;FGG;ITGAV;NRG1;CFLAR;AREG;HSPA1B;HSPA1A;PF4,4062,0.050002461962676645
346,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),2.4654758222564005e-08,10/55,0.18181818181818182,23.105263157894736,521.4748055736762,IFNB1;STAT1;CLCF1;LEP;STAT3;LIF;TYK2;JAK2;IL6ST;IL6R,4062,0.050002461962676645
346,Positive Regulation of Interleukin-6 Production (GO:0032755),4.156985881432907e-08,11/77,0.14285714285714285,17.402116402116402,382.4659121660166,IFIH1;SYK;LEP;STAT3;TWIST1;IL16;LGALS9;IL17D;IL6R;TLR2;MAPK13,4062,0.050002461962676645
346,Response to Cytokine (GO:0034097),4.332170582335487e-08,13/123,0.10569105691056911,12.44385026737968,272.1757423883953,HDAC4;IFITM1;CIITA;SRC;STAT1;OSMR;CXCL16;CASP8;SELL;LGALS9;IL6ST;JAK2;IL6R,4062,0.050002461962676645
346,Positive Regulation of Tumor Necrosis Factor Production (GO:0032760),7.359844703539289e-08,11/82,0.13414634146341464,16.172516580967287,344.17888204774107,IFIH1;SYK;IFNGR1;STAT3;HSPB1;TWIST1;LGALS9;AZU1;JAK2;TLR2;PF4,4062,0.050002461962676645
346,Regulation of Interleukin-8 Production (GO:0032677),7.525493962370102e-08,11/83,0.13253012048192772,15.947089947089948,337.25274730743286,ANXA1;SYK;LEP;STAT3;LGALS9;CD58;IL17D;IL6R;HSPA1B;TLR2;HSPA1A,4062,0.050002461962676645
346,Regulation of T Cell Proliferation (GO:0042129),7.525493962370102e-08,11/83,0.13253012048192772,15.947089947089948,337.25274730743286,LGALS3;ANXA1;IL15;CLCF1;LEP;TNFRSF14;TYK2;JAK2;IL6ST;TNFRSF21;HLA-DRB1,4062,0.050002461962676645
346,Positive Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),8.805785420194678e-08,11/85,0.12941176470588237,15.514514514514516,324.0465431120925,IFIH1;SYK;IFNGR1;STAT3;HSPB1;TWIST1;LGALS9;AZU1;JAK2;TLR2;PF4,4062,0.050002461962676645
346,Cellular Response to Virus (GO:0098586),8.805785420194678e-08,10/65,0.15384615384615385,18.894736842105264,393.8516325492772,IFIH1;HSP90AA1;IFNGR1;IFNB1;PTGES2;LGALS9;TYK2;JAK2;MAPK14;IFNL3,4062,0.050002461962676645
346,Regulation of miRNA Transcription (GO:1902893),9.841412657742694e-08,10/66,0.15151515151515152,18.55639097744361,383.9108215622402,SREBF1;JUN;MYC;STAT3;RARA;TWIST1;FOS;PPARA;AREG;VEGFA,4062,0.050002461962676645
346,Macrophage Differentiation (GO:0030225),2.359424919481827e-07,7/24,0.2916666666666667,42.20694910088388,832.7890242033293,CASP8;CSF1;IL15;LIF;CFLAR;HLA-DRB1;VEGFA,4062,0.050002461962676645
346,Interferon-Mediated Signaling Pathway (GO:0140888),2.8898494828420485e-07,9/55,0.16363636363636364,20.235146824493512,393.6007286626139,HDAC4;IFITM1;IFI27;IFNGR1;IFNB1;STAT1;TYK2;JAK2;IFNL3,4062,0.050002461962676645
346,Positive Regulation of Interleukin-8 Production (GO:0032757),9.348060833844684e-07,9/63,0.14285714285714285,17.230366492146597,313.6946208107819,SYK;LEP;STAT3;LGALS9;CD58;IL17D;HSPA1B;TLR2;HSPA1A,4062,0.050002461962676645
346,Granulocyte Chemotaxis (GO:0071621),1.0227605775378498e-06,9/64,0.140625,16.916230366492147,305.5575173573561,LGALS3;ANXA1;SYK;CCL7;PTGES2;PPBP;S100A8;VEGFA;PF4,4062,0.050002461962676645
346,Regulation of Monocyte Chemotactic Protein-1 Production (GO:0071637),1.4379430221297015e-06,5/10,0.5,101.51282051282053,1785.329817856251,SYK;GSTP1;TWIST1;APOD;LGALS9,4062,0.050002461962676645
346,Myeloid Leukocyte Differentiation (GO:0002573),2.878905395685876e-06,9/74,0.12162162162162163,14.306484091824403,239.76961990415532,CASP8;CSF1;IL15;LIF;LGALS9;CFLAR;MAPK14;HLA-DRB1;VEGFA,4062,0.050002461962676645
346,Regulation of Cytokine Production Involved in Inflammatory Response (GO:1900015),3.3830158625162405e-06,8/55,0.14545454545454545,17.511524822695037,288.3114928701292,NFKBIA;LEP;STAT3;APOD;JAK2;PPARA;MAPK14;IL17D,4062,0.050002461962676645
346,Interleukin-6-Mediated Signaling Pathway (GO:0070102),3.3830158625162405e-06,5/12,0.4166666666666667,72.5018315018315,1193.2632448189015,SRC;STAT3;IL6ST;JAK2;IL6R,4062,0.050002461962676645
346,Negative Regulation of Cellular Component Organization (GO:0051129),4.780381823812485e-06,9/80,0.1125,13.093503428950669,210.41358401404568,LGALS3;SRC;LAMP2;NR1H4;SPRY2;AREG;HSPA1B;VEGFA;HSPA1A,4062,0.050002461962676645
346,Positive Regulation of Erythrocyte Differentiation (GO:0045648),9.693651965939716e-06,6/27,0.2222222222222222,29.12960235640648,445.190090525153,STAT1;STAT3;MAPK14;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
346,Positive Regulation of Alpha-Beta T Cell Proliferation (GO:0046641),1.0864487177628196e-05,5/15,0.3333333333333333,50.74358974358975,768.7656511195227,HLA-A;TYK2;LGALS9;JAK2;CD55,4062,0.050002461962676645
346,Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1.0905984005475953e-05,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,ACVR1;LGALS3;SRC;GSTP1;CAV1;ITGAV;CFLAR;AREG,4062,0.050002461962676645
346,Mononuclear Cell Differentiation (GO:1903131),1.3769846512012905e-05,7/46,0.15217391304347827,18.377441211638104,273.3824888472053,CASP8;CSF1;IL15;LIF;CFLAR;HLA-DRB1;VEGFA,4062,0.050002461962676645
346,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.454070790203709e-05,8/68,0.11764705882352941,13.708333333333334,202.4938064855017,CASP8;IFI27;BAG3;ITGAV;TNFRSF10A;CFLAR;JAK2;IL6R,4062,0.050002461962676645
346,Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),1.470649314013164e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,IFNB1;IL15;STAT1;CLCF1;STAT3;TYK2;JAK2,4062,0.050002461962676645
346,Cellular Response to Type II Interferon (GO:0071346),1.470649314013164e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,IFNGR1;STAT1;CD58;LGALS9;TYK2;JAK2;TLR2,4062,0.050002461962676645
346,Collagen-Activated Signaling Pathway (GO:0038065),2.322029389394139e-05,4/8,0.5,101.0,1437.5971916079902,DDR1;ITGA2;JAK2;DDR2,4062,0.050002461962676645
346,Regulation of Acute Inflammatory Response (GO:0002673),2.544505526822403e-05,5/18,0.2777777777777778,39.0276134122288,551.3039505508597,GSTP1;OSMR;IL6ST;INS;PTGES,4062,0.050002461962676645
346,Negative Regulation of Apoptotic Signaling Pathway (GO:2001234),2.544505526822403e-05,8/74,0.10810810810810811,12.458333333333334,175.79196778707703,ACVR1;LGALS3;SRC;GSTP1;ITGAV;CFLAR;AREG;HSPA1A,4062,0.050002461962676645
346,Positive Regulation of Chemokine Production (GO:0032722),3.603293615392217e-05,7/54,0.12962962962962962,15.243192591775989,209.54780112784735,SYK;FFAR3;TWIST1;LGALS9;AZU1;IL6R;TLR2,4062,0.050002461962676645
346,Intracellular Receptor Signaling Pathway (GO:0030522),3.859761280629578e-05,6/35,0.17142857142857143,21.08531816565944,287.77059905823296,IFIH1;BECN1;STAT3;NR1H4;PPARA;AREG,4062,0.050002461962676645
346,Cellular Response to Vascular Endothelial Growth Factor Stimulus (GO:0035924),4.460213314931061e-05,6/36,0.16666666666666666,20.38144329896907,274.6176998194445,NOTCH1;HSPB1;SPRY2;MAPK14;PGF;VEGFA,4062,0.050002461962676645
346,Positive Regulation of Myeloid Cell Differentiation (GO:0045639),5.203977453024766e-05,6/37,0.16216216216216217,19.722979714000665,262.4200242351339,STAT1;STAT3;MAPK14;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
346,Type II Interferon-Mediated Signaling Pathway (GO:0060333),5.958318798726712e-05,4/10,0.4,67.3265306122449,885.3932781130271,IFNGR1;STAT1;TYK2;JAK2,4062,0.050002461962676645
346,Regulation of Erythrocyte Differentiation (GO:0045646),5.958318798726712e-05,6/38,0.15789473684210525,19.105670103092784,251.0820739334879,STAT1;STAT3;MAPK14;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
346,Mammary Gland Development (GO:0030879),6.53417986000327e-05,5/22,0.22727272727272727,29.838612368024133,388.9673545532963,CAV1;NRG1;JAK2;WNT2;VEGFA,4062,0.050002461962676645
346,Response to Type II Interferon (GO:0034341),6.561267242967169e-05,7/60,0.11666666666666667,13.513442174210578,175.91748523818214,CIITA;IFITM1;STAT1;LGALS9;CD58;CXCL16;TLR2,4062,0.050002461962676645
346,Cellular Response to Interleukin-6 (GO:0071354),7.695362850796686e-05,5/23,0.21739130434782608,28.17948717948718,360.6611683989916,SRC;STAT3;IL6ST;JAK2;IL6R,4062,0.050002461962676645
346,Regulation of Phagocytosis (GO:0050764),7.695362850796686e-05,7/62,0.11290322580645161,13.020725388601036,166.5760371840454,IL15RA;SYK;IL15;STAT3;ITGAV;AZU1;TLR2,4062,0.050002461962676645
346,Positive Regulation of Macrophage Differentiation (GO:0045651),8.073573750095829e-05,4/11,0.36363636363636365,57.70553935860058,733.2413213987782,CASP8;CSF1;LIF;PF4,4062,0.050002461962676645
346,Positive Regulation of Interleukin-1 Production (GO:0032732),8.073573750095829e-05,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,CASP8;STAT3;HSPB1;IL16;LGALS9;AZU1;JAK2,4062,0.050002461962676645
346,Positive Regulation of Peptidyl-Tyrosine Phosphorylation (GO:0050731),8.073573750095829e-05,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,FGF7;IL15;LIF;NRG1;JAK2;EFNA5;VEGFA,4062,0.050002461962676645
346,Type I Interferon-Mediated Signaling Pathway (GO:0060337),9.16882315703746e-05,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,HDAC4;IFITM1;IFI27;IFNB1;STAT1;TYK2,4062,0.050002461962676645
346,Regulation of Peptidyl-Tyrosine Phosphorylation (GO:0050730),9.98686019798752e-05,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,FGF7;EPHA7;IL15;LIF;EFNA5;VEGFA,4062,0.050002461962676645
346,Cellular Response to Type I Interferon (GO:0071357),9.98686019798752e-05,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,HDAC4;IFITM1;IFI27;IFNB1;STAT1;TYK2,4062,0.050002461962676645
346,Neutrophil Chemotaxis (GO:0030593),9.98686019798752e-05,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,LGALS3;SYK;PTGES2;PPBP;S100A8;PF4,4062,0.050002461962676645
346,T-helper Cell Lineage Commitment (GO:0002295),0.00010608157871208643,4/12,0.3333333333333333,50.48979591836735,621.4783262572987,TBX21;STAT3;IL6ST;IL6R,4062,0.050002461962676645
346,Positive Regulation of miRNA Transcription (GO:1902895),0.00016298471136313249,6/47,0.1276595744680851,14.904953482524515,176.74686266062798,SREBF1;JUN;MYC;STAT3;FOS;AREG,4062,0.050002461962676645
346,Positive Regulation of Osteoblast Differentiation (GO:0045669),0.0001828038159055781,6/48,0.125,14.549337260677468,170.70788117651412,FZD1;IFITM1;IL6ST;IL6R;ACVR2A;DDR2,4062,0.050002461962676645
346,Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0048010),0.00020687924211153943,5/29,0.1724137931034483,21.128205128205128,244.79950290336265,SRC;HSPB1;MAPK14;PGF;VEGFA,4062,0.050002461962676645
346,Interleukin-23-Mediated Signaling Pathway (GO:0038155),0.00021017596333127635,3/5,0.6,150.746192893401,1740.0227480112785,STAT3;TYK2;JAK2,4062,0.050002461962676645
346,Neutrophil Migration (GO:1990266),0.00021912449433830853,6/50,0.12,13.88659793814433,159.57344828850043,LGALS3;SYK;PTGES2;PPBP;S100A8;PF4,4062,0.050002461962676645
346,Negative Regulation of Cytokine Production Involved in Inflammatory Response (GO:1900016),0.00023483547244102147,5/30,0.16666666666666666,20.28205128205128,231.46246946256952,NFKBIA;STAT3;APOD;JAK2;PPARA,4062,0.050002461962676645
346,Regulation of Focal Adhesion Assembly (GO:0051893),0.00029163311436274065,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,SRC;APOD;TEK;EFNA5;S100A10;VEGFA,4062,0.050002461962676645
346,Positive Regulation of miRNA Metabolic Process (GO:2000630),0.00029163311436274065,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,SREBF1;JUN;MYC;STAT3;FOS;AREG,4062,0.050002461962676645
346,Regulation of Macrophage Derived Foam Cell Differentiation (GO:0010743),0.0003029715216507205,5/32,0.15625,18.77777777777778,208.10711759419505,NFKBIA;CSF1;ITGAV;PPARA;PF4,4062,0.050002461962676645
346,Response to Steroid Hormone (GO:0048545),0.0003029715216507205,5/32,0.15625,18.77777777777778,208.10711759419505,JUN;CAV1;AREG;HSPA1B;HSPA1A,4062,0.050002461962676645
346,Nuclear Receptor-Mediated Signaling Pathway (GO:0141193),0.0003029715216507205,5/32,0.15625,18.77777777777778,208.10711759419505,RXRA;NR1H4;RARA;PPARA;AREG,4062,0.050002461962676645
346,Regulation of Macrophage Differentiation (GO:0045649),0.00031108472324808863,4/16,0.25,33.6530612244898,371.4740483715657,CASP8;CSF1;LIF;PF4,4062,0.050002461962676645
346,Positive Regulation of Interleukin-12 Production (GO:0032735),0.0003418680646222759,5/33,0.15151515151515152,18.106227106227102,197.83659620108145,SYK;IL16;LGALS9;MAPK14;TLR2,4062,0.050002461962676645
346,Positive Regulation of Interleukin-1 Beta Production (GO:0032731),0.0003713682969220337,6/56,0.10714285714285714,12.216494845360824,132.26100624841683,CASP8;STAT3;HSPB1;LGALS9;AZU1;JAK2,4062,0.050002461962676645
346,Negative Regulation of Inflammatory Response to Antigenic Stimulus (GO:0002862),0.0003832744838727221,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,SYK;SRC;MAPK14;HLA-DRB1,4062,0.050002461962676645
346,Peptidyl-Tyrosine Phosphorylation (GO:0018108),0.0004439526640678744,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,DDR1;SYK;IL15;SRC;JAK2;DDR2,4062,0.050002461962676645
346,Regulation of Inflammatory Response to Antigenic Stimulus (GO:0002861),0.000476910179640988,4/18,0.2222222222222222,28.84256559766764,303.8404891137544,SYK;SRC;MAPK14;HLA-DRB1,4062,0.050002461962676645
346,Cellular Response to Heat (GO:0034605),0.0004955083409231894,5/36,0.1388888888888889,16.351530190239867,171.49530707153963,HSP90AA1;HSP90AB1;BAG3;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Peptidyl-Tyrosine Phosphorylation (GO:0018108),1.2050717810090662e-10,12/58,0.20689655172413793,27.41073080481036,780.6632374979766,PDGFRB;HCK;FLT1;IL15;FES;ERBB2;KDR;ABL2;FYN;JAK2;EGFR;IGF1R,4062,0.050002461962676645
213,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),3.3878392780942804e-08,13/121,0.10743801652892562,12.675579322638146,279.86718007082584,PDGFRB;FLT1;LIFR;ACVR2A;AHI1;HCK;ERBB3;AXL;ERBB2;KDR;FYN;IL6ST;JAK2,4062,0.050002461962676645
213,Regulation of T Cell Proliferation (GO:0042129),7.749060034508094e-08,11/83,0.13253012048192772,15.947089947089948,337.25274730743286,LGALS3;ANXA1;VCAM1;IL15;IL1B;LEP;TYK2;JAK2;IL6ST;FOXP3;IDO1,4062,0.050002461962676645
213,Peptidyl-Tyrosine Modification (GO:0018212),7.749060034508094e-08,9/46,0.1956521739130435,25.16867128909014,531.7309522424523,PDGFRB;HCK;FLT1;FES;ERBB2;KDR;ABL2;FYN;EGFR,4062,0.050002461962676645
213,Regulation of Interleukin-8 Production (GO:0032677),7.811271678031724e-07,10/83,0.12048192771084337,14.222782984859409,261.5745423882652,CD2;ANXA1;ANXA4;IL1B;LEP;TLR8;CD33;TLR3;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Regulation of Type II Interferon Production (GO:0032649),1.2889827812744698e-06,10/88,0.11363636363636363,13.307692307692308,237.09325581468232,CD2;AXL;IL1B;TLR8;HLA-A;TYK2;JAK2;FOXP3;TLR3;IL12RB2,4062,0.050002461962676645
213,Interferon-Mediated Signaling Pathway (GO:0140888),4.168707667900226e-06,8/55,0.14545454545454545,17.511524822695037,288.3114928701292,HCK;IFNA1;IFI27;OAS2;STAT1;TYK2;JAK2;JAK1,4062,0.050002461962676645
213,Positive Regulation of Myeloid Cell Differentiation (GO:0045639),4.168707667900226e-06,7/37,0.1891891891891892,23.90155440414508,393.14107245044136,STAT1;FES;HIF1A;GLUL;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Positive Regulation of Lymphocyte Proliferation (GO:0050671),4.219886360951922e-06,9/77,0.11688311688311688,13.673236834000615,224.33895481846685,ANXA1;VCAM1;IL15;IL1B;LEP;CD38;TYK2;JAK2;IL6ST,4062,0.050002461962676645
213,Positive Regulation of Type II Interferon Production (GO:0032729),5.946876444443896e-06,8/58,0.13793103448275862,16.458333333333332,263.9246654545614,CD2;IL1B;TLR8;HLA-A;TYK2;JAK2;TLR3;IL12RB2,4062,0.050002461962676645
213,Response to UV-A (GO:0070141),6.112736194253973e-06,5/13,0.38461538461538464,63.43589743589744,1013.7704525458294,CCND1;MMP1;MMP3;TIMP1;EGFR,4062,0.050002461962676645
213,Regulation of Endothelial Cell Proliferation (GO:0001936),1.1048047424380708e-05,9/87,0.10344827586206896,11.914216673378975,182.7223689793875,ANGPT1;STAT1;TNFSF12;LEP;FGF18;KDR;AKT1;HIF1A;CCL26,4062,0.050002461962676645
213,Positive Regulation of Erythrocyte Differentiation (GO:0045648),1.1085748906457471e-05,6/27,0.2222222222222222,29.12960235640648,445.190090525153,STAT1;HIF1A;GLUL;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Positive Regulation of Alpha-Beta T Cell Proliferation (GO:0046641),1.2039074432719782e-05,5/15,0.3333333333333333,50.74358974358975,768.7656511195227,HLA-A;TYK2;JAK2;CD55;TGFBR2,4062,0.050002461962676645
213,Positive Regulation of T Cell Proliferation (GO:0042102),1.2039074432719782e-05,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,ANXA1;VCAM1;IL15;IL1B;LEP;TYK2;JAK2;IL6ST,4062,0.050002461962676645
213,Positive Regulation of Blood Vessel Endothelial Cell Migration (GO:0043536),2.464043760786116e-05,7/50,0.14,16.664537896132064,238.06795841122283,ANXA1;ANGPT1;FGF18;KDR;HSPB1;AKT1;HIF1A,4062,0.050002461962676645
213,Mesoderm Formation (GO:0001707),4.8560907195240177e-05,5/20,0.25,33.82051282051282,458.2410056420293,SMAD2;ITGA3;ITGB4;ITGA2;SNAI1,4062,0.050002461962676645
213,Regulation of Blood Vessel Endothelial Cell Migration (GO:0043535),5.489122248608639e-05,7/57,0.12280701754385964,14.32642487046632,191.56735099815583,ANGPT1;FGF18;KDR;HSPB1;AKT1;PPARG;HIF1A,4062,0.050002461962676645
213,Type II Interferon-Mediated Signaling Pathway (GO:0060333),6.44708075231225e-05,4/10,0.4,67.3265306122449,885.3932781130271,STAT1;TYK2;JAK2;JAK1,4062,0.050002461962676645
213,Regulation of Erythrocyte Differentiation (GO:0045646),6.44708075231225e-05,6/38,0.15789473684210525,19.105670103092784,251.0820739334879,STAT1;HIF1A;GLUL;ACVR2A;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Positive Regulation of Interleukin-8 Production (GO:0032757),9.863056953522087e-05,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,CD2;IL1B;LEP;TLR8;TLR3;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Type I Interferon-Mediated Signaling Pathway (GO:0060337),0.00011285729214102792,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,IFNA1;IFI27;STAT1;OAS2;TYK2;JAK1,4062,0.050002461962676645
213,Cellular Response to Virus (GO:0098586),0.0001182190922447184,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,IFIH1;HSP90AA1;IFNA1;TYK2;JAK2;HIF1A;JAK1,4062,0.050002461962676645
213,Cellular Response to Type I Interferon (GO:0071357),0.000124160815026067,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,IFNA1;IFI27;STAT1;OAS2;TYK2;JAK1,4062,0.050002461962676645
213,T-helper Cell Lineage Commitment (GO:0002295),0.00013277192371122308,4/12,0.3333333333333333,50.48979591836735,621.4783262572987,IRF4;TBX21;IL6ST;JAK1,4062,0.050002461962676645
213,Positive Regulation of miRNA Transcription (GO:1902895),0.00019663926934941584,6/47,0.1276595744680851,14.904953482524515,176.74686266062798,SREBF1;JUN;PPARG;FOS;HIF1A;EGFR,4062,0.050002461962676645
213,Regulation of Protein Modification by Small Protein Conjugation or Removal (GO:1903320),0.00020659163404659648,5/28,0.17857142857142858,22.0479375696767,259.44921421372527,HSP90AA1;CTNNB1;HIF1A;HSPA1B;HSPA1A,4062,0.050002461962676645
213,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),0.00023530070294936384,6/49,0.12244897959183673,14.210261328218651,164.99131524160097,ERBB3;ERBB2;AKT1;ABL2;CTNNB1;EGFR,4062,0.050002461962676645
213,Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),0.00023530070294936384,6/49,0.12244897959183673,14.210261328218651,164.99131524160097,PDGFRB;JUN;FGF9;HDAC1;STAT1;AKT1,4062,0.050002461962676645
213,Positive Regulation of miRNA Metabolic Process (GO:2000630),0.0003594939843871384,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,SREBF1;JUN;PPARG;FOS;HIF1A;EGFR,4062,0.050002461962676645
213,Regulation of Smooth Muscle Cell Proliferation (GO:0048660),0.00039131837056067046,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,PDGFRB;HDAC1;STAT1;AKT1;CTNNB1;PPARG,4062,0.050002461962676645
213,T Cell Homeostasis (GO:0043029),0.00039131837056067046,4/16,0.25,33.6530612244898,371.4740483715657,LGALS3;FASN;AKT1;FOXP3,4062,0.050002461962676645
213,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),0.0004301488584696046,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,STAT1;LEP;TYK2;JAK2;IL6ST;JAK1,4062,0.050002461962676645
213,Interleukin-27-Mediated Signaling Pathway (GO:0070106),0.0004523749939495045,3/6,0.5,100.49238578680205,1091.0444080855816,OAS2;STAT1;MX1,4062,0.050002461962676645
419,Interferon-Mediated Signaling Pathway (GO:0140888),7.420145952715597e-11,12/55,0.21818181818181817,29.327560613557644,855.2920970079202,IFITM3;IFNAR2;HCK;IFITM1;IFI27;IFNG;OAS1;IFNGR1;IFNB1;STAT1;TYK2;JAK2,4062,0.050002461962676645
419,Response to Cytokine (GO:0034097),3.6728787306977707e-10,15/123,0.12195121951219512,14.783783783783784,401.5068286335162,IFITM3;IFNAR2;SERPINA3;IFITM1;IL1R1;STAT1;MX1;LIFR;TNFRSF11A;CXCL16;BST2;LAMP3;TIMP1;IL6ST;JAK2,4062,0.050002461962676645
419,Peptidyl-Tyrosine Phosphorylation (GO:0018108),1.9683820786873507e-09,11/58,0.1896551724137931,24.46054260947878,616.212284858616,DDR1;PDGFRB;PDGFRA;HCK;ERBB2;ABL2;PTK6;JAK2;EGFR;PTK2;FGFR1,4062,0.050002461962676645
419,Response to Interferon-Beta (GO:0035456),3.776544496817995e-08,8/29,0.27586206896551724,39.24404761904762,859.036683068409,IFITM3;IFNAR2;BST2;IFITM1;OAS1;IFNB1;STAT1;CALM1,4062,0.050002461962676645
419,Cellular Response to Lipopolysaccharide (GO:0071222),4.446279832690715e-08,13/125,0.104,12.220397249809016,264.80608315630144,CXCL6;CXCL9;GSTP1;MMP3;HMGB2;IL18;PPBP;NFKB1;CXCL5;HCK;CTSG;JAK2;B2M,4062,0.050002461962676645
419,Cellular Response to Type II Interferon (GO:0071346),8.03935811522041e-08,9/47,0.19148936170212766,24.50509782309176,512.7141737733722,HCK;IFNG;IFNGR1;STAT1;CCL5;CD58;TYK2;JAK2;CALM1,4062,0.050002461962676645
419,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.2561600422087598e-07,10/68,0.14705882352941177,17.91470054446461,365.19992253654686,SMAD4;IFI27;IFNG;BAG3;CD70;ITGAV;TNFRSF10A;CFLAR;INHBA;JAK2,4062,0.050002461962676645
419,Negative Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001237),2.042774977275829e-07,10/72,0.1388888888888889,16.755517826825127,331.8944867164616,LGALS3;GDNF;GSTP1;FGG;AKT1;ITGAV;BRCA1;CFLAR;AREG;THBS1,4062,0.050002461962676645
419,Positive Regulation of miRNA Metabolic Process (GO:2000630),2.042774977275829e-07,9/53,0.16981132075471697,21.157068062827225,418.8067602545073,SREBF1;NOTCH3;JUN;PPARG;FOS;FGF13;AREG;EGFR;NFKB1,4062,0.050002461962676645
419,Regulation of Smooth Muscle Cell Proliferation (GO:0048660),2.2153731500035082e-07,9/54,0.16666666666666666,20.68586387434555,405.8859583398362,PDGFRB;IFNG;STAT1;CCL5;IL18;AKT1;CTNNB1;PPARG;THBS1,4062,0.050002461962676645
419,Type I Interferon-Mediated Signaling Pathway (GO:0060337),5.265612959373095e-07,8/42,0.19047619047619047,24.223039215686278,452.64739011158383,IFITM3;IFNAR2;IFITM1;IFI27;OAS1;IFNB1;STAT1;TYK2,4062,0.050002461962676645
419,Cellular Response to Type I Interferon (GO:0071357),6.207194563268797e-07,8/43,0.18604651162790697,23.529761904761905,435.0499090286752,IFITM3;IFNAR2;IFITM1;IFI27;OAS1;IFNB1;STAT1;TYK2,4062,0.050002461962676645
419,Peptidyl-Tyrosine Modification (GO:0018212),9.690429261483746e-07,8/46,0.17391304347826086,21.66885964912281,388.4690218387859,PDGFRB;PDGFRA;HCK;ERBB2;ABL2;EGFR;PTK2;FGFR1,4062,0.050002461962676645
419,Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001236),9.690429261483746e-07,9/65,0.13846153846153847,16.613313388182497,297.7530303415938,LGALS3;CD40LG;TNFRSF12A;GSTP1;ITGAV;CFLAR;LTBR;AREG;THBS1,4062,0.050002461962676645
419,Regulation of Phosphorylation (GO:0042325),9.690429261483746e-07,9/65,0.13846153846153847,16.613313388182497,297.7530303415938,FZD7;NLRC5;HSPB1;INHBA;INHA;AREG;THBS1;EGFR;PTK2,4062,0.050002461962676645
419,Regulation of miRNA Transcription (GO:1902893),1.081527918585662e-06,9/66,0.13636363636363635,16.32102507577845,290.26230553359085,SREBF1;NOTCH3;JUN;PPARG;FOS;PPARA;FGF13;AREG;EGFR,4062,0.050002461962676645
419,Positive Regulation of miRNA Transcription (GO:1902895),1.0898623319947855e-06,8/47,0.1702127659574468,21.112179487179485,374.7303730596972,NOTCH3;SREBF1;JUN;PPARG;FOS;FGF13;AREG;EGFR,4062,0.050002461962676645
419,Response to Interferon-Alpha (GO:0035455),1.2161140996485764e-06,6/19,0.3157894736842105,47.07454401268834,828.8006483109033,IFITM3;IFNAR2;BST2;IFITM1;OAS1;LAMP3,4062,0.050002461962676645
419,Type II Interferon-Mediated Signaling Pathway (GO:0060333),1.2161140996485764e-06,5/10,0.5,101.51282051282053,1785.329817856251,IFNG;IFNGR1;STAT1;TYK2;JAK2,4062,0.050002461962676645
419,Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),1.4212878900490895e-06,8/49,0.16326530612244897,20.08028455284553,349.5177192586028,PDGFRB;JUN;STAT1;CCL5;IL18;AKT1;FGF13;THBS1,4062,0.050002461962676645
419,Positive Regulation of Protein Serine/Threonine Kinase Activity (GO:0071902),2.716958586676729e-06,9/75,0.12,14.089005235602096,234.445014035586,PDGFRB;IFNG;ERBB2;FGF18;FGF13;THBS1;EGFR;EZH2;FGFR1,4062,0.050002461962676645
419,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),3.1699503064898566e-06,8/55,0.14545454545454545,17.511524822695037,288.3114928701292,IFNAR2;IFNG;IFNB1;STAT1;CCL5;TYK2;JAK2;IL6ST,4062,0.050002461962676645
419,ERBB Signaling Pathway (GO:0038127),4.566320783540581e-06,8/58,0.13793103448275862,16.458333333333332,263.9246654545614,ERBB2;AKT1;ABL2;CTNNB1;PTK6;AREG;EGFR;PTK2,4062,0.050002461962676645
419,Response to UV-A (GO:0070141),4.634877738985257e-06,5/13,0.38461538461538464,63.43589743589744,1013.7704525458294,CCND1;MMP1;MMP3;TIMP1;EGFR,4062,0.050002461962676645
419,Response to Type II Interferon (GO:0034341),5.646368302479399e-06,8/60,0.13333333333333333,15.823717948717947,249.44826809728173,IFITM3;BST2;IFITM1;STAT1;CCL5;CD58;CALM1;CXCL16,4062,0.050002461962676645
419,Granulocyte Chemotaxis (GO:0071621),8.611582261447385e-06,8/64,0.125,14.69047619047619,224.03413671771912,CXCL6;LGALS3;CXCL9;CCL21;CCL5;CXCR2;PPBP;CXCL5,4062,0.050002461962676645
419,Cellular Response to Virus (GO:0098586),9.406667936926528e-06,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,IFNAR2;IFNG;OAS1;IFNGR1;IFNB1;CCL5;TYK2;JAK2,4062,0.050002461962676645
419,Positive Regulation of T Cell Proliferation (GO:0042102),9.406667936926528e-06,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,CD40LG;CD70;CCL5;IL18;TNFSF9;TYK2;JAK2;IL6ST,4062,0.050002461962676645
419,Negative Regulation of Viral Process (GO:0048525),1.0099592324555372e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,IFITM3;BST2;IFITM1;OAS1;IFNB1;STAT1;CCL5;MX1,4062,0.050002461962676645
419,Positive Regulation of MAP Kinase Activity (GO:0043406),1.0099592324555372e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,PDGFRB;ERBB2;FGF18;TNFRSF11A;FGF13;THBS1;EZH2;FGFR1,4062,0.050002461962676645
419,Positive Regulation of Chemotaxis (GO:0050921),1.1328709701404568e-05,7/46,0.15217391304347827,18.377441211638104,273.3824888472053,PDGFRB;PDGFRA;CCL21;HSPB1;FGF13;THBS1;FGFR1,4062,0.050002461962676645
419,Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),1.259927769955161e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,IFNAR2;IFNG;IFNB1;STAT1;PTK6;TYK2;JAK2,4062,0.050002461962676645
419,Negative Regulation of Viral Genome Replication (GO:0045071),1.4196101957745795e-05,7/48,0.14583333333333334,17.479211424238596,254.74171296424544,IFITM3;BST2;IFITM1;OAS1;IFNB1;CCL5;MX1,4062,0.050002461962676645
419,Epidermal Growth Factor Receptor Signaling Pathway (GO:0007173),1.618479192368185e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,ERBB2;AKT1;ABL2;CTNNB1;AREG;EGFR;PTK2,4062,0.050002461962676645
419,Regulation of MAP Kinase Activity (GO:0043405),1.964730957400077e-05,8/73,0.1095890410958904,12.650641025641026,179.84491143075044,PDGFRB;GSTP1;ERBB2;FGF18;FGF13;THBS1;EZH2;FGFR1,4062,0.050002461962676645
419,Regulation of Macrophage Derived Foam Cell Differentiation (GO:0010743),1.964730957400077e-05,6/32,0.1875,23.5218080888184,334.1469681320765,IL18;ITGAV;PPARG;APOB;PPARA;NFKB1,4062,0.050002461962676645
419,Positive Regulation of Homotypic Cell-Cell Adhesion (GO:0034112),2.0984708486433472e-05,5/18,0.2777777777777778,39.0276134122288,551.3039505508597,CCL5;CTNNB1;CTSG;IL6ST;JAK2,4062,0.050002461962676645
419,Regulation of Blood Vessel Endothelial Cell Migration (GO:0043535),4.283519495912201e-05,7/57,0.12280701754385964,14.32642487046632,191.56735099815583,FGF18;HSPB1;AKT1;PPARG;FGF13;THBS1;FGFR1,4062,0.050002461962676645
419,Cellular Response to Interferon-Beta (GO:0035458),5.837843232305845e-05,5/22,0.22727272727272727,29.838612368024133,388.9673545532963,IFNAR2;OAS1;IFNB1;STAT1;CALM1,4062,0.050002461962676645
419,Positive Regulation of Phosphate Metabolic Process (GO:0045937),7.12160006833567e-05,5/23,0.21739130434782608,28.17948717948718,360.6611683989916,IFNG;FZD7;AREG;THBS1;EGFR,4062,0.050002461962676645
419,Neutrophil Chemotaxis (GO:0030593),0.00010444453461099164,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,CXCL6;LGALS3;CXCL9;CXCR2;PPBP;CXCL5,4062,0.050002461962676645
419,Regulation of Viral Genome Replication (GO:0045069),0.00010567931892524064,7/66,0.10606060606060606,12.135505400895758,150.08231117190402,IFITM3;BST2;IFITM1;OAS1;IFNB1;CCL5;MX1,4062,0.050002461962676645
419,Granulocyte Activation (GO:0036230),0.00015315263920153772,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,CXCL6;CCL5;CXCR2;CTSG,4062,0.050002461962676645
419,Positive Regulation of NK T Cell Proliferation (GO:0051142),0.0002174431855380699,3/5,0.6,150.746192893401,1740.0227480112785,IL18;TYK2;JAK2,4062,0.050002461962676645
419,Neutrophil Migration (GO:1990266),0.0002240745091828304,6/50,0.12,13.88659793814433,159.57344828850043,CXCL6;LGALS3;CXCL9;CXCR2;PPBP;CXCL5,4062,0.050002461962676645
419,Positive Regulation of Blood Vessel Endothelial Cell Migration (GO:0043536),0.0002240745091828304,6/50,0.12,13.88659793814433,159.57344828850043,FGF18;HSPB1;AKT1;FGF13;THBS1;FGFR1,4062,0.050002461962676645
419,Myofibril Assembly (GO:0030239),0.0002492010999484605,6/51,0.11764705882352941,13.577319587628866,154.4327783623843,PDGFRB;PDGFRA;KRT19;TTR;TPM1;CFLAR,4062,0.050002461962676645
419,Positive Regulation of Alpha-Beta T Cell Proliferation (GO:0046641),0.00025815621649329145,4/15,0.26666666666666666,36.71428571428572,415.5389408534144,IL18;TYK2;JAK2;CD55,4062,0.050002461962676645
419,Regulation of Extrinsic Apoptotic Signaling Pathway via Death Domain Receptors (GO:1902041),0.00030871241659396456,5/32,0.15625,18.77777777777778,208.10711759419505,LGALS3;FGG;BRCA1;CFLAR;THBS1,4062,0.050002461962676645
419,Nuclear Receptor-Mediated Signaling Pathway (GO:0141193),0.00030871241659396456,5/32,0.15625,18.77777777777778,208.10711759419505,RXRA;NR1H4;PPARG;PPARA;AREG,4062,0.050002461962676645
419,Positive Regulation of Locomotion (GO:0040017),0.00030871241659396456,5/32,0.15625,18.77777777777778,208.10711759419505,PDGFRB;PDGFRA;CCL21;SPOCK2;THBS1,4062,0.050002461962676645
419,Detection of Muscle Stretch (GO:0035995),0.0003590421200500319,3/6,0.5,100.49238578680205,1091.0444080855816,TTR;CTNNB1;PTK2,4062,0.050002461962676645
419,Interleukin-27-Mediated Signaling Pathway (GO:0070106),0.0003590421200500319,3/6,0.5,100.49238578680205,1091.0444080855816,OAS1;STAT1;MX1,4062,0.050002461962676645
419,Negative Regulation of Lymphocyte Differentiation (GO:0045620),0.0003590421200500319,3/6,0.5,100.49238578680205,1091.0444080855816,IFNB1;INHBA;INHA,4062,0.050002461962676645
419,Regulation of NK T Cell Proliferation (GO:0051140),0.0003590421200500319,3/6,0.5,100.49238578680205,1091.0444080855816,IL18;TYK2;JAK2,4062,0.050002461962676645
419,Regulation of Endothelial Cell Chemotaxis (GO:2001026),0.0003803712065266598,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,HSPB1;FGF13;THBS1;FGFR1,4062,0.050002461962676645
419,Regulation of Interleukin-17 Production (GO:0032660),0.00043738297165062427,5/35,0.14285714285714285,16.897435897435898,179.61044178472525,IFNG;IL18;NR1H4;TYK2;JAK2,4062,0.050002461962676645
419,Endoderm Formation (GO:0001706),0.0004867469986323315,5/36,0.1388888888888889,16.351530190239867,171.49530707153963,DUSP2;COL4A2;COL6A1;ITGAV;INHBA,4062,0.050002461962676645
187,Regulation of Tumor Necrosis Factor Production (GO:0032680),1.195138312094483e-08,14/131,0.10687022900763359,12.662531017369728,299.00106479140754,IFNGR1;AZU1;NOD2;IL1A;CLEC7A;OAS3;LGALS9;CD47;EPHB2;S100A9;CD33;TLR3;HAVCR2;LTF,4062,0.050002461962676645
187,Positive Regulation of T Cell Activation (GO:0050870),1.6039649631740132e-08,13/111,0.11711711711711711,13.97609953072138,323.91045676322443,CD274;HLA-DRB5;VCAM1;TYK2;NOD2;CD40LG;CD28;HLA-DRA;CCR7;LGALS9;CD47;IL6ST;B2M,4062,0.050002461962676645
187,Positive Regulation of Tumor Necrosis Factor Production (GO:0032760),6.473716071387409e-08,11/82,0.13414634146341464,16.172516580967287,344.17888204774107,IL1A;IFNGR1;CLEC7A;OAS3;LGALS9;NOD2;AZU1;EPHB2;S100A9;TLR3;HAVCR2,4062,0.050002461962676645
187,Positive Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),9.129415794873565e-08,11/85,0.12941176470588237,15.514514514514516,324.0465431120925,IL1A;IFNGR1;CLEC7A;OAS3;LGALS9;NOD2;AZU1;EPHB2;S100A9;TLR3;HAVCR2,4062,0.050002461962676645
187,Negative Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001237),2.3343968711951427e-07,10/72,0.1388888888888889,16.755517826825127,331.8944867164616,BMP4;LGALS3;IL1A;FGG;AKT1;SNAI2;ITGA6;AREG;ICAM1;HSPA1A,4062,0.050002461962676645
187,Positive Regulation of Lymphocyte Proliferation (GO:0050671),4.045703611906133e-07,10/77,0.12987012987012986,15.501178318931656,296.6238324657464,CD274;VCAM1;CD40LG;GPR183;CD28;CD38;TYK2;EPHB2;IL6ST;S100A9,4062,0.050002461962676645
187,Regulation of Type II Interferon Production (GO:0032649),1.356871431641657e-06,10/88,0.11363636363636363,13.307692307692308,237.09325581468232,CD274;CLEC7A;TLR8;CCR7;LGALS9;TYK2;CD47;INHA;TLR3;HAVCR2,4062,0.050002461962676645
187,Regulation of Interleukin-1 Beta Production (GO:0032651),8.005611356367193e-06,9/82,0.10975609756097561,12.73348633723015,201.86705189659827,CASP8;CLEC7A;TLR8;CCR7;CD36;LGALS9;NOD2;AZU1;CD33,4062,0.050002461962676645
187,Regulation of Interleukin-8 Production (GO:0032677),8.655047541572275e-06,9/83,0.10843373493975904,12.560775435120984,197.79543589447545,CLEC7A;TLR8;LGALS9;NOD2;TLR5;CD33;TLR3;ELANE;HSPA1A,4062,0.050002461962676645
187,Positive Regulation of Immune System Process (GO:0002684),8.81679668239379e-06,7/41,0.17073170731707318,21.085339835416036,331.06423432395894,HLA-DRB5;TNFRSF18;HLA-DRA;LGALS9;AQP3;B2M;VEGFA,4062,0.050002461962676645
187,Canonical Wnt Signaling Pathway (GO:0060070),1.0691773746889773e-05,8/63,0.12698412698412698,14.958333333333334,229.98870557377373,FZD1;WNT10B;RARG;WNT2B;FZD4;FZD7;WNT7A;WNT2,4062,0.050002461962676645
187,Positive Regulation of Interleukin-8 Production (GO:0032757),1.0691773746889773e-05,8/63,0.12698412698412698,14.958333333333334,229.98870557377373,CLEC7A;TLR8;LGALS9;NOD2;TLR5;TLR3;ELANE;HSPA1A,4062,0.050002461962676645
187,Ephrin Receptor Signaling Pathway (GO:0048013),1.0691773746889773e-05,7/43,0.16279069767441862,19.9119170984456,305.80839613375537,EPHB6;EFNA1;EFNB3;MMP2;EFNA5;EPHB2;EPHB4,4062,0.050002461962676645
187,Regulation of miRNA Transcription (GO:1902893),1.4845790402532214e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,BMP4;SMAD3;MYC;FOS;AREG;HIF1A;EGFR;VEGFA,4062,0.050002461962676645
187,Regulation of Interleukin-10 Production (GO:0032653),1.654508306706829e-05,7/46,0.15217391304347827,18.377441211638104,273.3824888472053,CD274;CD40LG;CLEC7A;CD28;NOD2;LGALS9;CD47,4062,0.050002461962676645
187,Regulation of Interleukin-12 Production (GO:0032655),2.920062442504933e-05,7/50,0.14,16.664537896132064,238.06795841122283,CD40LG;CLEC7A;TLR8;CCR7;LGALS9;CD47;TLR3,4062,0.050002461962676645
187,Interferon-Mediated Signaling Pathway (GO:0140888),5.450249600961754e-05,7/55,0.12727272727272726,14.924870466321243,203.26608191930924,IFNAR2;HDAC4;IFI27;IFNGR1;STAT1;OAS3;TYK2,4062,0.050002461962676645
187,Positive Regulation of Interleukin-1 Beta Production (GO:0032731),5.701381203915841e-05,7/56,0.125,14.619541080680976,197.27895870167836,CASP8;CLEC7A;TLR8;CD36;LGALS9;NOD2;AZU1,4062,0.050002461962676645
187,Response to Retinoic Acid (GO:0032526),8.374025287833822e-05,7/60,0.11666666666666667,13.513442174210578,175.91748523818214,WNT10B;RARG;FZD4;FZD7;ATM;AQP3;WNT2,4062,0.050002461962676645
187,Positive Regulation of Phosphate Metabolic Process (GO:0045937),0.00010073398726582744,5/23,0.21739130434782608,28.17948717948718,360.6611683989916,FZD7;ITGA6;AREG;S100A9;EGFR,4062,0.050002461962676645
187,Positive Regulation of Interleukin-1 Production (GO:0032732),0.00011111777314946708,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,CASP8;CLEC7A;TLR8;CD36;LGALS9;NOD2;AZU1,4062,0.050002461962676645
187,Type I Interferon-Mediated Signaling Pathway (GO:0060337),0.0001250287919624929,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,HDAC4;IFNAR2;IFI27;STAT1;OAS3;TYK2,4062,0.050002461962676645
187,Heterophilic Cell-Cell Adhesion via Plasma Membrane Cell Adhesion Molecules (GO:0007157),0.0001250287919624929,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,CD164;VCAM1;CEACAM6;NRXN1;ITGAL;ICAM1,4062,0.050002461962676645
187,Regulation of Phosphorylation (GO:0042325),0.0001309358566991311,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,FZD7;ITGA6;INHA;AREG;S100A9;EGFR;ENG,4062,0.050002461962676645
187,Cellular Response to Type I Interferon (GO:0071357),0.00013745061360741857,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,HDAC4;IFNAR2;IFI27;STAT1;OAS3;TYK2,4062,0.050002461962676645
187,Regulation of Nitric Oxide Biosynthetic Process (GO:0045428),0.0001677118047725496,6/45,0.13333333333333333,15.670896114195084,189.8997840048912,HSP90AB1;SMAD3;CLEC7A;AKT1;CD36;CD47,4062,0.050002461962676645
187,Positive Regulation of Cell-Matrix Adhesion (GO:0001954),0.0001677118047725496,6/45,0.13333333333333333,15.670896114195084,189.8997840048912,CSF1;CEACAM6;CCR7;CD36;S100A10;VEGFA,4062,0.050002461962676645
187,Regulation of B Cell Proliferation (GO:0030888),0.0001677118047725496,6/45,0.13333333333333333,15.670896114195084,189.8997840048912,TNFRSF13B;GPR183;CD38;ATM;EPHB2;S100A9,4062,0.050002461962676645
187,Response to UV-A (GO:0070141),0.00019576987215728475,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,CCND1;MMP2;TIMP1;EGFR,4062,0.050002461962676645
187,Positive Regulation of miRNA Transcription (GO:1902895),0.00021141103551236987,6/47,0.1276595744680851,14.904953482524515,176.74686266062798,SMAD3;MYC;FOS;AREG;HIF1A;EGFR,4062,0.050002461962676645
187,Autocrine Signaling (GO:0035425),0.0002782485013710512,3/5,0.6,150.746192893401,1740.0227480112785,FZD1;HILPDA;S100A9,4062,0.050002461962676645
187,Reg of T Cell Act via T Cell Rec Contact With Ag Bound to MHC Mol on Ag Presenting Cell (GO:2001188),0.0002782485013710512,3/5,0.6,150.746192893401,1740.0227480112785,LGALS3;LGALS9;HAVCR2,4062,0.050002461962676645
187,Regulation of Interleukin-2 Production (GO:0032663),0.000289112709120828,6/50,0.12,13.88659793814433,159.57344828850043,IL1A;CLEC7A;CD28;EZR;CD34;HAVCR2,4062,0.050002461962676645
187,Positive Regulation of Interleukin-10 Production (GO:0032733),0.0003009979300704636,5/30,0.16666666666666666,20.28205128205128,231.46246946256952,CD40LG;CLEC7A;CD28;NOD2;LGALS9,4062,0.050002461962676645
187,Positive Regulation of Nitric Oxide Biosynthetic Process (GO:0045429),0.0003009979300704636,5/30,0.16666666666666666,20.28205128205128,231.46246946256952,HSP90AB1;SMAD3;CLEC7A;AKT1;CD36,4062,0.050002461962676645
187,Leukocyte Cell-Cell Adhesion (GO:0007159),0.0003347911515631575,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,VCAM1;CD40LG;ITGAL;EZR;ICAM1,4062,0.050002461962676645
187,Positive Regulation of Nitric Oxide Metabolic Process (GO:1904407),0.0003347911515631575,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,HSP90AB1;SMAD3;CLEC7A;AKT1;CD36,4062,0.050002461962676645
187,Cellular Response to Mechanical Stimulus (GO:0071260),0.0003600408819293095,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,CASP8;CHEK1;TLR8;LTBR;TLR5;TLR3,4062,0.050002461962676645
187,Positive Regulation of miRNA Metabolic Process (GO:2000630),0.0003600408819293095,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,SMAD3;MYC;FOS;AREG;HIF1A;EGFR,4062,0.050002461962676645
187,Chondrocyte Differentiation (GO:0002062),0.00037569186537153663,5/32,0.15625,18.77777777777778,208.10711759419505,BMP4;WNT10B;WNT2B;WNT7A;FGFR3,4062,0.050002461962676645
187,Positive Regulation of Chemokine Production (GO:0032722),0.0003881592263561368,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,CLEC7A;OAS3;LGALS9;AZU1;HIF1A;TLR3,4062,0.050002461962676645
187,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),0.0004247219030427437,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,IFNAR2;STAT5A;STAT1;TYK2;IL6ST;FGFR3,4062,0.050002461962676645
187,Positive Regulation of Interleukin-12 Production (GO:0032735),0.0004247219030427437,5/33,0.15151515151515152,18.106227106227102,197.83659620108145,CD40LG;CLEC7A;CCR7;LGALS9;TLR3,4062,0.050002461962676645
187,Interleukin-27-Mediated Signaling Pathway (GO:0070106),0.0004503203760653526,3/6,0.5,100.49238578680205,1091.0444080855816,STAT1;OAS3;MX1,4062,0.050002461962676645
467,Cytokine-Mediated Signaling Pathway (GO:0019221),9.4004149643537e-17,27/255,0.10588235294117647,13.397322786735623,595.5344261254334,CSF1R;CXCL9;CSF2RB;TNF;CCL8;CCL7;CCL5;CCL3;IL12B;CCL2;CCL18;IL6R;IL11;SMAD4;IL1R1;IL10RB;IFNGR2;IL16;TNFRSF1B;HCK;CXCL10;CD4;IL1B;KIT;IL6ST;CCL26;PF4,4062,0.050002461962676645
467,+ Reg of Phosphatidylinositol 3-Kinase/Prot Kinase B Signal Transduction (GO:0051897),1.4436651022364154e-10,17/162,0.10493827160493827,12.59223666855097,354.1916662154982,PDGFRA;CSF1R;TGFB2;FLT1;IL1R1;NRXN1;TNF;THBS1;CD19;IL1B;CCL5;SELENOP;KIT;CCL3;HCST;FGFR1;DDR2,4062,0.050002461962676645
467,Antimicrobial Humoral Immune Response Mediated by Antimicrobial Peptide (GO:0061844),1.8081022447608267e-09,14/116,0.1206896551724138,14.53573687539532,367.4873937393072,CXCL9;CCL20;REG1A;CXCL14;NPPB;CXCL10;CCL8;CCL7;CCL5;CCL3;CCL2;CCL18;CCL26;PF4,4062,0.050002461962676645
467,Monocyte Chemotaxis (GO:0002548),5.9248254276919934e-09,8/23,0.34782608695652173,54.958333333333336,1319.426693390558,FLT1;CCL7;CCL5;CCL3;CCL2;IL6R;CCL26;PF4,4062,0.050002461962676645
467,Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),3.1210159548312214e-08,13/121,0.10743801652892562,12.675579322638146,279.86718007082584,PDGFRA;CSF1R;YES1;FLT1;NPPB;NPPC;HCK;CD4;CD8A;IL6ST;ANGPTL1;EPHA2;DDR2,4062,0.050002461962676645
467,Granulocyte Chemotaxis (GO:0071621),8.182863090386759e-08,10/64,0.15625,19.24561403508772,404.21386647588594,CXCL10;CXCL9;TGFB2;CCL8;CCL7;CCL5;CCL3;CCL2;CCL26;PF4,4062,0.050002461962676645
467,Chemokine-Mediated Signaling Pathway (GO:0070098),8.182863090386759e-08,9/47,0.19148936170212766,24.50509782309176,512.7141737733722,CXCL10;CXCL9;CCL8;CCL7;CCL5;CCL3;CCL2;CCL18;CCL26,4062,0.050002461962676645
467,Cellular Response to Chemokine (GO:1990869),9.485560958449386e-08,9/48,0.1875,23.87555376560612,494.7906183286474,CXCL10;CXCL9;CCL8;CCL7;CCL5;CCL3;CCL2;CCL18;CCL26,4062,0.050002461962676645
467,Eosinophil Chemotaxis (GO:0048245),1.64845375736944e-06,6/19,0.3157894736842105,47.07454401268834,828.8006483109033,CCL8;CCL7;CCL5;CCL3;CCL2;CCL26,4062,0.050002461962676645
467,Eosinophil Migration (GO:0072677),1.64845375736944e-06,6/19,0.3157894736842105,47.07454401268834,828.8006483109033,CCL8;CCL7;CCL5;CCL3;CCL2;CCL26,4062,0.050002461962676645
467,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.7378771761291974e-06,9/68,0.1323529411764706,15.76617268613009,276.15342747426,SMAD4;TGFB2;TNFRSF10B;BAX;FASLG;INHBA;TNFRSF1B;TNF;IL6R,4062,0.050002461962676645
467,Glial Cell Migration (GO:0008347),3.15075865443656e-06,4/5,0.8,404.0612244897959,6808.079065245498,TGFB2;CCL3;CCL2;CD9,4062,0.050002461962676645
467,Secondary Palate Development (GO:0062009),6.40247303391122e-06,5/13,0.38461538461538464,63.43589743589744,1013.7704525458294,SMAD4;TGFB2;TGFB3;WNT7A;TGFBR2,4062,0.050002461962676645
467,Regulation of Natural Killer Cell Chemotaxis (GO:2000501),7.770619581704073e-06,4/6,0.6666666666666666,202.0204081632653,3183.512051346897,KLRK1;CCL7;CCL5;CCL3,4062,0.050002461962676645
467,Cellular Response to Virus (GO:0098586),1.4197227463918628e-05,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,IFNAR2;CXCL10;IFNA1;IL10RB;IFNGR2;CCL5;BAX;MAPK14,4062,0.050002461962676645
467,Regulation of T Cell Activation (GO:0050863),1.9718631630928265e-05,8/68,0.11764705882352941,13.708333333333334,202.4938064855017,HLA-DRB5;CD4;CD209;CCL5;CCL2;PDCD1;TNFRSF1B;HLA-DQA1,4062,0.050002461962676645
467,Regulation of Endothelial Cell Apoptotic Process (GO:2000351),1.988282328398892e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,CDH5;IL11;RGCC;CCL2;FASLG;THBS1;TNF,4062,0.050002461962676645
467,Positive Regulation of Epithelial to Mesenchymal Transition (GO:0010718),2.337339243867961e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,SMAD4;TGFB2;RGCC;TGFB3;IL1B;TGFBR2;EZH2,4062,0.050002461962676645
467,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),4.713237205942285e-05,7/55,0.12727272727272726,14.924870466321243,203.26608191930924,IFNAR2;CCL5;IL12B;CSF2RB;IL6ST;TNF;IL6R,4062,0.050002461962676645
467,Positive Regulation of Macrophage Migration (GO:1905523),4.95429604299999e-05,5/20,0.25,33.82051282051282,458.2410056420293,CSF1R;CCL5;CCL3;CCL2;THBS1,4062,0.050002461962676645
467,Endoderm Formation (GO:0001706),5.236992712283831e-05,6/36,0.16666666666666666,20.38144329896907,274.6176998194445,DUSP5;DUSP2;COL12A1;INHBA;ITGA5;MMP9,4062,0.050002461962676645
467,Positive Regulation of SMAD Protein Signal Transduction (GO:0060391),7.792125571247759e-05,6/39,0.15384615384615385,18.52577319587629,240.5204111443618,SMAD4;TGFB2;TGFB3;INHBA;GDF6;TGFBR2,4062,0.050002461962676645
467,Canonical Wnt Signaling Pathway (GO:0060070),9.80937364826458e-05,7/63,0.1111111111111111,12.787564766839376,162.19489427978257,RARG;FZD5;FZD4;FZD8;WNT7A;WNT2;WNT3,4062,0.050002461962676645
467,Collagen Fibril Organization (GO:0030199),0.00015944322276980992,6/45,0.13333333333333333,15.670896114195084,189.8997840048912,TGFB2;BMP1;COL5A1;COL12A1;CYP1B1;DDR2,4062,0.050002461962676645
467,Peptidyl-Tyrosine Modification (GO:0018212),0.00017641500700692686,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,CSF1R;PDGFRA;HCK;FLT1;DDR2;FGFR1,4062,0.050002461962676645
467,Regulation of Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:2001239),0.00021324784802534449,5/28,0.17857142857142858,22.0479375696767,259.44921421372527,IL1B;SNAI2;INHBA;TNF;PF4,4062,0.050002461962676645
467,Positive Regulation of Macrophage Chemotaxis (GO:0010759),0.0002400618826988797,4/14,0.2857142857142857,40.38775510204081,469.325501273126,CSF1R;CCL5;CCL2;THBS1,4062,0.050002461962676645
467,Reg of Epithelial to Mesenchymal Transition Inv in Endocardial Cushion Formation (GO:1905005),0.00024895458309345776,3/5,0.6,150.746192893401,1740.0227480112785,TGFB2;TGFB3;TGFBR2,4062,0.050002461962676645
467,Mammary Gland Epithelium Development (GO:0061180),0.0002994896462675029,4/15,0.26666666666666666,36.71428571428572,415.5389408534144,CSF1R;WNT2;WNT3;EPHA2,4062,0.050002461962676645
467,Leukocyte Cell-Cell Adhesion (GO:0007159),0.000310328039976845,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,VCAM1;CD209;CCL5;SELENOP;OLR1,4062,0.050002461962676645
467,Natural Killer Cell Mediated Immunity (GO:0002228),0.000310328039976845,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,KLRK1;TUBB;GZMB;NKG7;HCST,4062,0.050002461962676645
467,Natural Killer Cell Mediated Cytotoxicity (GO:0042267),0.0003559333133166361,5/32,0.15625,18.77777777777778,208.10711759419505,KLRK1;TUBB;GZMB;NKG7;HCST,4062,0.050002461962676645
467,Interferon-Mediated Signaling Pathway (GO:0140888),0.00040415005153563815,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,IFITM3;IFNAR2;HCK;IFNA1;IL10RB;IFNGR2,4062,0.050002461962676645
467,Positive Regulation of Leukocyte Chemotaxis (GO:0002690),0.0004236898949578887,6/56,0.10714285714285714,12.216494845360824,132.26100624841683,CSF1R;CXCL10;CCL5;CCL2;IL6R;THBS1,4062,0.050002461962676645
467,Cellular Response to Interleukin-1 (GO:0071347),0.0004543114174800813,6/57,0.10526315789473684,11.97634930260764,128.42832253074832,PTGIS;IL1R1;IL1B;CCL5;CCL3;CCL2,4062,0.050002461962676645
467,Regulation of Blood Vessel Endothelial Cell Migration (GO:0043535),0.0004543114174800813,6/57,0.10526315789473684,11.97634930260764,128.42832253074832,RGCC;MAPK14;TNF;THBS1;EPHA2;FGFR1,4062,0.050002461962676645
467,Peptidyl-Tyrosine Phosphorylation (GO:0018108),0.0004876467034689525,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,PDGFRA;HCK;CSF1R;FLT1;DDR2;FGFR1,4062,0.050002461962676645
454,Negative Regulation of Type II Interferon Production (GO:0032689),3.48266967625658e-08,8/28,0.2857142857142857,41.208333333333336,914.9825046859704,CD274;DDIT3;TNFSF4;NR1H4;PDCD1LG2;GAS6;TLR4;VSIR,4062,0.050002461962676645
454,Regulation of B Cell Proliferation (GO:0030888),5.6955160024252486e-08,9/45,0.2,25.869109947643977,551.9382828830934,TYROBP;TNFRSF13B;IL7;CLCF1;GPR183;BCL2;MZB1;ATM;TNFRSF4,4062,0.050002461962676645
454,Regulation of Type II Interferon Production (GO:0032649),9.880056399201881e-08,11/88,0.125,14.907785336356763,305.716586855594,CD274;FZD5;DDIT3;TNFSF4;NR1H4;TLR8;PDCD1LG2;GAS6;IL12RB1;TLR4;VSIR,4062,0.050002461962676645
454,Regulation of Interleukin-6 Production (GO:0032675),1.2449021572272698e-07,12/114,0.10526315789473684,12.32665832290363,249.4525147409786,IFIH1;APP;IL1A;IL33;TYROBP;C5AR2;TNFSF4;WNT5A;HLA-B;TLR8;GAS6;TLR4,4062,0.050002461962676645
454,Positive Regulation of Interleukin-6 Production (GO:0032755),3.726104019273598e-06,9/77,0.11688311688311688,13.673236834000615,224.33895481846685,IFIH1;APP;IL1A;IL33;TYROBP;TNFSF4;WNT5A;TLR8;TLR4,4062,0.050002461962676645
454,Positive Regulation of Lymphocyte Proliferation (GO:0050671),3.726104019273598e-06,9/77,0.11688311688311688,13.673236834000615,224.33895481846685,CD274;CD209;IL7;CLCF1;GPR183;TNFSF4;BCL2;PDCD1LG2;TNFRSF4,4062,0.050002461962676645
454,Positive Regulation of Interleukin-1 Beta Production (GO:0032731),3.877681940697863e-06,8/56,0.14285714285714285,17.145833333333332,279.79416672039247,APP;CASP8;TYROBP;FZD5;WNT5A;TLR8;NLRP1;TLR4,4062,0.050002461962676645
454,Sprouting Angiogenesis (GO:0002040),4.910038591185237e-06,8/58,0.13793103448275862,16.458333333333332,263.9246654545614,EFNB2;RAMP2;VEGFB;VEGFC;VEGFD;FGF13;DLL1;EPHB4,4062,0.050002461962676645
454,Wound Healing (GO:0042060),5.175005326818556e-06,9/81,0.1111111111111111,12.910994764397904,206.0710655736609,SMAD3;ERBB3;FZD7;WNT5A;WNT7A;NRG1;CFLAR;FGF13;INS,4062,0.050002461962676645
454,Regulation of Interleukin-1 Beta Production (GO:0032651),5.517969628609353e-06,9/82,0.10975609756097561,12.73348633723015,201.86705189659827,APP;CASP8;TYROBP;FZD5;WNT5A;APOA1;TLR8;NLRP1;TLR4,4062,0.050002461962676645
454,Positive Regulation of Tumor Necrosis Factor Production (GO:0032760),5.517969628609353e-06,9/82,0.10975609756097561,12.73348633723015,201.86705189659827,IFIH1;APP;IL1A;IL33;TYROBP;FZD5;WNT5A;TLR4;PF4,4062,0.050002461962676645
454,Response to Retinoic Acid (GO:0032526),5.9061761274924e-06,8/60,0.13333333333333333,15.823717948717947,249.44826809728173,RARG;FZD7;WNT5A;PTK6;ATM;SOX9;WNT9A;AQP3,4062,0.050002461962676645
454,Positive Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),7.246703270940964e-06,9/85,0.10588235294117647,12.228988702121796,190.02666552150015,IFIH1;APP;IL1A;IL33;TYROBP;FZD5;WNT5A;TLR4;PF4,4062,0.050002461962676645
454,Positive Regulation of Interleukin-1 Production (GO:0032732),8.343776375023782e-06,8/63,0.12698412698412698,14.958333333333334,229.98870557377373,APP;CASP8;TYROBP;FZD5;WNT5A;TLR8;NLRP1;TLR4,4062,0.050002461962676645
454,Regulation of Chemokine Production (GO:0032642),8.343776375023782e-06,7/43,0.16279069767441862,19.9119170984456,305.80839613375537,APP;IL33;IL7;TNFSF4;WNT5A;SNAI2;TLR4,4062,0.050002461962676645
454,Regulation of miRNA Transcription (GO:1902893),1.1029316237376818e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,NOTCH2;APP;NOTCH3;SMAD3;SOX9;FGF13;ESR1;POU5F1,4062,0.050002461962676645
454,Regulation of Interleukin-10 Production (GO:0032653),1.230574907521566e-05,7/46,0.15217391304347827,18.377441211638104,273.3824888472053,CD274;TYROBP;TNFSF4;PDCD1LG2;DLL1;TLR4;VSIR,4062,0.050002461962676645
454,Negative Regulation of Interleukin-10 Production (GO:0032693),1.3261938442163607e-05,5/16,0.3125,46.12820512820513,681.9340623795607,CD274;TYROBP;PDCD1LG2;DLL1;VSIR,4062,0.050002461962676645
454,Regulation of Lymphocyte Proliferation (GO:0050670),2.3899894087946457e-05,5/18,0.2777777777777778,39.0276134122288,551.3039505508597,CD209;MZB1;TNFSF9;TNFSF8;TNFRSF1B,4062,0.050002461962676645
454,Myeloid Leukocyte Differentiation (GO:0002573),2.3899894087946457e-05,8/74,0.10810810810810811,12.458333333333334,175.79196778707703,IL33;BMP2;CASP8;TYROBP;GPR183;TNFRSF11A;CFLAR;DHRS2,4062,0.050002461962676645
454,Regulation of Activated T Cell Proliferation (GO:0046006),2.591391292471746e-05,6/33,0.18181818181818182,22.649484536082475,317.3982287063927,CD274;CLCF1;IGF2;TNFSF9;PDCD1LG2;IL12RB1,4062,0.050002461962676645
454,Aortic Valve Development (GO:0003176),8.612831696166633e-05,6/41,0.14634146341463414,17.465390279823268,221.44186896112137,EFNA1;BMP2;JAG1;SNAI2;SOX9;TNFRSF1B,4062,0.050002461962676645
454,Negative Regulation of Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:2001240),9.314043939533696e-05,5/24,0.20833333333333334,26.695006747638327,335.64237766536246,IL1A;BCL2;SNAI2;NRG1;PF4,4062,0.050002461962676645
454,Negative Regulation of Signal Transduction in Absence of Ligand (GO:1901099),9.314043939533696e-05,5/24,0.20833333333333334,26.695006747638327,335.64237766536246,IL1A;BCL2;SNAI2;NRG1;PF4,4062,0.050002461962676645
454,Notch Signaling Pathway (GO:0007219),9.318062429678268e-05,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,NOTCH2;NOTCH3;BMP2;JAG1;SNAI2;DLL1,4062,0.050002461962676645
454,Cellular Response to Retinoic Acid (GO:0071300),9.318062429678268e-05,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,FZD7;WNT5A;PTK6;ATM;SOX9;WNT9A,4062,0.050002461962676645
454,Positive Regulation of T Cell Proliferation (GO:0042102),9.78856789169354e-05,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,CD274;CD209;TNFSF4;IGF2;TNFSF9;PDCD1LG2;IL12RB1,4062,0.050002461962676645
454,Positive Regulation of Production of Molecular Mediator of Immune Response (GO:0002702),0.00010336765622162552,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,CLCF1;TNFSF4;WNT5A;MZB1;IL2RG;TNFRSF4,4062,0.050002461962676645
454,Regulation of Ossification (GO:0030278),0.00011580357299372422,6/44,0.13636363636363635,16.08410200759631,197.07505682737636,GDF10;BMP2;SMAD3;WNT5A;SOX9;ACVR1B,4062,0.050002461962676645
454,Positive Regulation of Nuclear Division (GO:0051785),0.0001264437325249906,5/26,0.19230769230769232,24.15018315018315,293.4914392101124,IL1A;RGCC;EGF;IGF2;INS,4062,0.050002461962676645
454,Skin Development (GO:0043588),0.00013618794659720043,7/69,0.10144927536231885,11.546548554237004,139.32697987988573,COL1A1;JAG1;COL5A1;WNT5A;COL5A2;KRT10;DLL1,4062,0.050002461962676645
454,Mononuclear Cell Differentiation (GO:1903131),0.0001430879679790124,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,IL33;CASP8;FLT3LG;CFLAR;IL2RG;GAS6,4062,0.050002461962676645
454,Activation of Protein Kinase B Activity (GO:0032148),0.00014455356800158222,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,WNT5A;NRG1;GAS6;INS,4062,0.050002461962676645
454,Negative Regulation of Secretion (GO:0051048),0.00014455356800158222,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,ERBB3;EGF;NR1H3;NRG1,4062,0.050002461962676645
454,Regulation of Extrinsic Apoptotic Signaling Pathway in Absence of Ligand (GO:2001239),0.00016768831042035122,5/28,0.17857142857142858,22.0479375696767,259.44921421372527,IL1A;BCL2;SNAI2;NRG1;PF4,4062,0.050002461962676645
454,Positive Regulation of Response to Cytokine Stimulus (GO:0060760),0.00018995878250273183,4/14,0.2857142857142857,40.38775510204081,469.325501273126,IFIH1;IL7;WNT5A;GAS6,4062,0.050002461962676645
454,Positive Regulation of Epithelial to Mesenchymal Transition (GO:0010718),0.00018995878250273183,6/49,0.12244897959183673,14.210261328218651,164.99131524160097,COL1A1;BMP2;JAG1;SMAD3;RGCC;EZH2,4062,0.050002461962676645
454,Regulation of Mast Cell Chemotaxis (GO:0060753),0.0002012044032443284,3/5,0.6,150.746192893401,1740.0227480112785,VEGFB;VEGFC;VEGFD,4062,0.050002461962676645
454,Negative Regulation of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903556),0.0002096638989567683,6/50,0.12,13.88659793814433,159.57344828850043,CD274;C5AR2;NR1H4;GAS6;TLR4;VSIR,4062,0.050002461962676645
454,Positive Regulation of Nitric Oxide Biosynthetic Process (GO:0045429),0.00022009248644826775,5/30,0.16666666666666666,20.28205128205128,231.46246946256952,APP;SMAD3;HBB;ESR1;TLR4,4062,0.050002461962676645
454,Regulation of Immunoglobulin Production (GO:0002637),0.00025519237982351764,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,CLCF1;TNFSF4;MZB1;IL2RG;TNFRSF4,4062,0.050002461962676645
454,Positive Regulation of Nitric Oxide Metabolic Process (GO:1904407),0.00025519237982351764,5/31,0.16129032258064516,19.500986193293887,219.27708359619595,APP;SMAD3;HBB;ESR1;TLR4,4062,0.050002461962676645
454,B Cell Differentiation (GO:0030183),0.0002755697519382022,6/53,0.11320754716981132,12.998245229216934,144.90663187900708,ADGRG3;HDAC5;CD79A;CLCF1;FLT3LG;MS4A1,4062,0.050002461962676645
454,Positive Regulation of Chemokine Production (GO:0032722),0.0003016537103112566,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,APP;IL33;IL7;TNFSF4;WNT5A;TLR4,4062,0.050002461962676645
454,Regulation of Receptor Signaling Pathway via JAK-STAT (GO:0046425),0.0003295755893859876,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,EGF;CYP1B1;PTK6;VHL;CSHL1;IL7R,4062,0.050002461962676645
454,Positive Regulation of Leukocyte Chemotaxis (GO:0002690),0.0003594200464411901,6/56,0.10714285714285714,12.216494845360824,132.26100624841683,APP;VEGFB;VEGFC;VEGFD;GAS6;CMKLR1,4062,0.050002461962676645
454,Positive Regulation of Glial Cell Differentiation (GO:0045687),0.0003705468618373968,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,BMP2;CLCF1;CXCR4;TNFRSF1B,4062,0.050002461962676645
454,Negative Regulation of Response to Stimulus (GO:0048585),0.0003844089545424236,6/57,0.10526315789473684,11.97634930260764,128.42832253074832,ERBB3;IGFBP3;NR1H2;APOA1;NR1H3;VHL,4062,0.050002461962676645
454,Regulation of Interleukin-17 Production (GO:0032660),0.0004108092355421032,5/35,0.14285714285714285,16.897435897435898,179.61044178472525,DDIT3;TNFSF4;NR1H4;TLR4;VSIR,4062,0.050002461962676645
454,Positive Regulation of Macromolecule Metabolic Process (GO:0010604),0.0004108092355421032,5/35,0.14285714285714285,16.897435897435898,179.61044178472525,APP;RAMP3;NR1H2;NR1H3;WNT7A,4062,0.050002461962676645
454,Positive Regulation of Mitotic Nuclear Division (GO:0045840),0.0004108092355421032,5/35,0.14285714285714285,16.897435897435898,179.61044178472525,IL1A;RGCC;EGF;IGF2;INS,4062,0.050002461962676645
454,ERBB Signaling Pathway (GO:0038127),0.0004108092355421032,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,PIGR;ERBB3;EGF;NRG1;PTK6;SOX9,4062,0.050002461962676645
454,Regulation of Steroid Biosynthetic Process (GO:0050810),0.0004448911382894302,4/18,0.2222222222222222,28.84256559766764,303.8404891137544,CHGA;BMP2;NR1H4;BMP5,4062,0.050002461962676645
470,Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),8.756267089871185e-08,9/47,0.19148936170212766,24.50509782309176,512.7141737733722,TSLP;IFNB1;STAT6;PTK6;TYK2;JAK2;FGFR3;CCR2;TNFRSF1A,4062,0.050002461962676645
470,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),3.0191791664877573e-07,9/55,0.16363636363636364,20.235146824493512,393.6007286626139,TSLP;IFNB1;STAT6;TYK2;JAK2;IL6ST;FGFR3;CCR2;TNFRSF1A,4062,0.050002461962676645
470,Interferon-Mediated Signaling Pathway (GO:0140888),3.0191791664877573e-07,9/55,0.16363636363636364,20.235146824493512,393.6007286626139,IFITM3;HDAC4;IFITM1;IFNGR1;IFNB1;IFNGR2;TYK2;JAK2;IFNL3,4062,0.050002461962676645
470,Positive Regulation of Alpha-Beta T Cell Proliferation (GO:0046641),3.49881885898637e-07,6/15,0.4,68.01030927835052,1310.0878886918515,CD81;IL18;XCL1;TYK2;JAK2;TGFBR2,4062,0.050002461962676645
470,Regulation of Viral Genome Replication (GO:0045069),1.370295198158128e-06,9/66,0.13636363636363635,16.32102507577845,290.26230553359085,IFITM3;IFIH1;BST2;IFITM1;SLPI;IFNB1;CD28;IFIT1;IFNL3,4062,0.050002461962676645
470,Negative Regulation of Viral Genome Replication (GO:0045071),1.5759875632181496e-06,8/48,0.16666666666666666,20.58333333333333,361.7667929621448,IFITM3;IFIH1;BST2;IFITM1;SLPI;IFNB1;IFIT1;IFNL3,4062,0.050002461962676645
470,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.6197010555660764e-06,9/68,0.1323529411764706,15.76617268613009,276.15342747426,SMAD4;TGFB2;BAG3;FASN;ITGAV;CFLAR;JAK2;FGFR3;TNFRSF1A,4062,0.050002461962676645
470,Regulation of miRNA Transcription (GO:1902893),1.6238423666240988e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,TGFB2;RARA;TWIST1;FOS;PPARA;ETS1;POU5F1;PPARD,4062,0.050002461962676645
470,Negative Regulation of Viral Process (GO:0048525),1.6238423666240988e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,IFITM3;IFIH1;BST2;IFITM1;SLPI;IFNB1;IFIT1;IFNL3,4062,0.050002461962676645
470,Negative Regulation of Type 2 Immune Response (GO:0002829),1.7106678074134773e-05,4/7,0.5714285714285714,134.6734693877551,2009.18359177183,IFNB1;TBX21;CCR2;IL27RA,4062,0.050002461962676645
470,Positive Regulation of Epithelial to Mesenchymal Transition (GO:0010718),2.5011253974161375e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,COL1A1;SMAD4;TGFB2;SNAI1;TWIST1;CTNNB1;TGFBR2,4062,0.050002461962676645
470,Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),2.5011253974161375e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,XBP1;IGFBP5;HDAC1;MMP2;IL18;AKT1;THBS1,4062,0.050002461962676645
470,Negative Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001237),2.65584049706935e-05,8/72,0.1111111111111111,12.848958333333334,184.0459923030108,GSTP1;AKT1;ITGAV;BRCA1;CFLAR;THBS1;HSPA1B;ICAM1,4062,0.050002461962676645
470,Positive Regulation of Lymphocyte Proliferation (GO:0050671),4.200145141620948e-05,8/77,0.1038961038961039,11.914855072463768,164.45204250576472,CD40LG;CD81;GPR183;IL18;CD28;TYK2;JAK2;IL6ST,4062,0.050002461962676645
470,Cellular Response to Type III Interferon (GO:0071358),7.172852855334385e-05,4/10,0.4,67.3265306122449,885.3932781130271,IFNGR1;IFNGR2;TYK2;IFNL3,4062,0.050002461962676645
470,Type II Interferon-Mediated Signaling Pathway (GO:0060333),7.172852855334385e-05,4/10,0.4,67.3265306122449,885.3932781130271,IFNGR1;IFNGR2;TYK2;JAK2,4062,0.050002461962676645
470,Type III Interferon-Mediated Signaling Pathway (GO:0038196),7.172852855334385e-05,4/10,0.4,67.3265306122449,885.3932781130271,IFNGR1;IFNGR2;TYK2;IFNL3,4062,0.050002461962676645
470,Response to Reactive Oxygen Species (GO:0000302),7.64237907368276e-05,7/60,0.11666666666666667,13.513442174210578,175.91748523818214,GSTP1;MMP3;FYN;ATM;FOS;HBA1;SOD1,4062,0.050002461962676645
470,Negative Regulation of Myotube Differentiation (GO:0010832),0.0001009190048313642,4/11,0.36363636363636365,57.70553935860058,733.2413213987782,HDAC4;HDAC5;XBP1;HDAC1,4062,0.050002461962676645
470,Positive Regulation of Receptor Signaling Pathway via STAT (GO:1904894),0.00011177206906422014,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,TSLP;CYP1B1;PTK6;TYK2;JAK2;IL7R,4062,0.050002461962676645
470,Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001236),0.00011293316934427988,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,ACVR1;CD40LG;GSTP1;ITGAV;LTB;CFLAR;THBS1,4062,0.050002461962676645
470,Cellular Response to Virus (GO:0098586),0.00011293316934427988,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,IFIH1;IFNGR1;IFNB1;IFNGR2;TYK2;JAK2;IFNL3,4062,0.050002461962676645
470,Positive Regulation of T Cell Proliferation (GO:0042102),0.00011293316934427988,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,CD40LG;IL18;CD28;TYK2;JAK2;IL6ST;CCR2,4062,0.050002461962676645
470,Cellular Response to Type I Interferon (GO:0071357),0.00012056839040121834,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,HDAC4;IFITM3;IFITM1;IFNB1;TYK2;IFIT1,4062,0.050002461962676645
470,Negative Regulation of miRNA Transcription (GO:1902894),0.00012284255963529157,5/25,0.2,25.35897435897436,313.3915485176811,RARA;TWIST1;PPARA;POU5F1;PPARD,4062,0.050002461962676645
470,Regulation of Interleukin-10 Production (GO:0032653),0.00016833757504444016,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,CD40LG;TSLP;CD28;XCL1;THBS1;FOXP3,4062,0.050002461962676645
470,Negative Regulation of miRNA Metabolic Process (GO:2000629),0.00016833757504444016,5/27,0.18518518518518517,23.05128205128205,275.60325810758144,RARA;TWIST1;PPARA;POU5F1;PPARD,4062,0.050002461962676645
470,Cardiac Left Ventricle Morphogenesis (GO:0003214),0.00016833757504444016,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,SMAD4;FOXF1;RBPJ;TGFBR2,4062,0.050002461962676645
470,Response to UV-A (GO:0070141),0.00016833757504444016,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,CCND1;MMP1;MMP2;MMP3,4062,0.050002461962676645
470,Positive Regulation of Type 2 Immune Response (GO:0002830),0.00016833757504444016,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,CD81;IL18;RARA;XCL1,4062,0.050002461962676645
470,Regulation of Endothelial Cell Apoptotic Process (GO:2000351),0.00018201388604677585,6/47,0.1276595744680851,14.904953482524515,176.74686266062798,CDH5;IL11;XBP1;CD40LG;THBS1;ICAM1,4062,0.050002461962676645
470,Regulation of Vascular Endothelial Growth Factor Production (GO:0010574),0.0002358941636936436,5/29,0.1724137931034483,21.128205128205128,244.79950290336265,CXCL17;CYP1B1;BRCA1;IL6ST;CCR2,4062,0.050002461962676645
470,Positive Regulation of NK T Cell Proliferation (GO:0051142),0.0002433775651527153,3/5,0.6,150.746192893401,1740.0227480112785,IL18;TYK2;JAK2,4062,0.050002461962676645
470,Epithelial to Mesenchymal Transition (GO:0001837),0.00028107835259264544,6/51,0.11764705882352941,13.577319587628866,154.4327783623843,SMAD4;TGFB2;SNAI1;CTNNB1;RBPJ;TGFBR2,4062,0.050002461962676645
470,Regulation of Smooth Muscle Cell Proliferation (GO:0048660),0.0003547182689429167,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,IGFBP5;HDAC1;IL18;AKT1;CTNNB1;THBS1,4062,0.050002461962676645
470,Positive Regulation of Chemokine Production (GO:0032722),0.0003547182689429167,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,TSLP;IL18;FFAR3;TWIST1;FFAR2;AZU1,4062,0.050002461962676645
470,Regulation of NK T Cell Proliferation (GO:0051140),0.000404882099002082,3/6,0.5,100.49238578680205,1091.0444080855816,IL18;TYK2;JAK2,4062,0.050002461962676645
470,Negative Regulation of Striated Muscle Cell Differentiation (GO:0051154),0.0004322071364776758,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,HDAC4;HDAC5;XBP1;HDAC1,4062,0.050002461962676645
470,Mesenchymal Cell Differentiation (GO:0048762),0.0004997397074846422,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,SMAD4;TGFB2;SNAI1;CTNNB1;RBPJ;TGFBR2,4062,0.050002461962676645
133,Negative Regulation of Inflammatory Response (GO:0050728),4.085329837851934e-08,13/121,0.10743801652892562,12.675579322638146,279.86718007082584,LYN;IL10;GSTP1;NR1H2;STAT3;APOA1;MAPK14;IL22RA1;FGR;NLRP3;SAA2;FYN;TEK,4062,0.050002461962676645
133,Peptidyl-Tyrosine Phosphorylation (GO:0018108),4.085329837851934e-08,10/58,0.1724137931034483,21.657894736842103,476.8344315355531,PDGFRB;FGR;LYN;FLT1;FES;KDR;FYN;EPHA3;PTK2;IGF1R,4062,0.050002461962676645
133,Peptidyl-Tyrosine Modification (GO:0018212),8.591806670245922e-08,9/46,0.1956521739130435,25.16867128909014,531.7309522424523,LYN;PDGFRB;FGR;FLT1;FES;KDR;FYN;PTK2;EPHA3,4062,0.050002461962676645
133,Positive Regulation of Blood Vessel Endothelial Cell Migration (GO:0043536),1.484463858481482e-07,9/50,0.18,22.70859404929128,461.8831728517062,ANXA1;TGFB1;ANGPT1;FGF18;KDR;HSPB1;MAPK14;ETS1;HIF1A,4062,0.050002461962676645
133,Positive Regulation of Vasculature Development (GO:1904018),1.012868139650222e-06,11/109,0.10091743119266056,11.70078825180866,213.0208576016094,ITGB1;TGFB1;FLT1;ADM2;FGF18;KDR;HSPB1;BRCA1;TEK;ETS1;HIF1A,4062,0.050002461962676645
133,Growth Hormone Receptor Signaling Pathway via JAK-STAT (GO:0060397),1.745650993943465e-06,5/10,0.5,101.51282051282053,1785.329817856251,LYN;STAT3;STAT6;TYK2;JAK1,4062,0.050002461962676645
133,Intermediate Filament Organization (GO:0045109),3.021420452798737e-06,9/72,0.125,14.7621540762902,251.00893697509483,KRT19;KRT4;KRT17;KRT16;KRT24;KRT10;KRT20;KRT6C;KRT6B,4062,0.050002461962676645
133,Growth Hormone Receptor Signaling Pathway (GO:0060396),3.043270145487751e-06,6/21,0.2857142857142857,40.79381443298969,690.6248819207933,LYN;STAT3;STAT6;TYK2;PTK2;JAK1,4062,0.050002461962676645
133,Positive Regulation of Myeloid Cell Differentiation (GO:0045639),4.361741421980335e-06,7/37,0.1891891891891892,23.90155440414508,393.14107245044136,STAT1;FES;STAT3;MAPK14;ETS1;HIF1A;HSPA1B,4062,0.050002461962676645
133,Regulation of Erythrocyte Differentiation (GO:0045646),5.15436507546457e-06,7/38,0.18421052631578946,23.129366538525822,375.9263140997042,LYN;STAT1;STAT3;MAPK14;ETS1;HIF1A;HSPA1B,4062,0.050002461962676645
133,Regulation of Blood Vessel Endothelial Cell Migration (GO:0043535),5.4186302078264256e-06,8/57,0.14035087719298245,16.795068027210885,271.6737617174621,TGFB1;ANGPT1;FGF18;KDR;HSPB1;MAPK14;ETS1;HIF1A,4062,0.050002461962676645
133,Regulation of Interleukin-1 Beta Production (GO:0032651),7.284420419000455e-06,9/82,0.10975609756097561,12.73348633723015,201.86705189659827,APP;CASP8;FZD5;GSTP1;STAT3;HSPB1;APOA1;NLRP3;CCL19,4062,0.050002461962676645
133,Regulation of T Cell Proliferation (GO:0042129),7.89266016957403e-06,9/83,0.10843373493975904,12.560775435120984,197.79543589447545,IL10;TNFSF18;LGALS3;ANXA1;TNFSF8;TYK2;CCL19;IL6ST;IDO1,4062,0.050002461962676645
133,Positive Regulation of Interleukin-1 Production (GO:0032732),1.0464662976859682e-05,8/63,0.12698412698412698,14.958333333333334,229.98870557377373,APP;CASP8;FZD5;STAT3;HSPB1;NLRP3;SAA2;CCL19,4062,0.050002461962676645
133,Ephrin Receptor Signaling Pathway (GO:0048013),1.0464662976859682e-05,7/43,0.16279069767441862,19.9119170984456,305.80839613375537,LYN;EPHA7;MMP2;FYN;EFNA5;PTK2;EPHA3,4062,0.050002461962676645
133,Positive Regulation of Erythrocyte Differentiation (GO:0045648),1.0642377610128124e-05,6/27,0.2222222222222222,29.12960235640648,445.190090525153,STAT1;STAT3;MAPK14;ETS1;HIF1A;HSPA1B,4062,0.050002461962676645
133,Positive Regulation of Endothelial Cell Migration (GO:0010595),1.090484320683229e-05,9/88,0.10227272727272728,11.76280734309762,179.2323929326818,TGFB1;ANGPT1;FGF18;KDR;HSPB1;TEK;MAPK14;ETS1;HIF1A,4062,0.050002461962676645
133,Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1.1672617801779252e-05,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,APP;LGALS3;GSTP1;TNFSF10;ITGAV;LTB;CFLAR;LTBR,4062,0.050002461962676645
133,Cellular Response to Virus (GO:0098586),1.1672617801779252e-05,8/65,0.12307692307692308,14.432017543859647,218.3203584146422,IFIH1;HSP90AA1;NLRP3;TYK2;CCL19;MAPK14;HIF1A;JAK1,4062,0.050002461962676645
133,Regulation of miRNA Transcription (GO:1902893),1.2906308724270237e-05,8/66,0.12121212121212122,14.182471264367816,212.8339025491534,IL10;APP;SREBF1;TGFB1;MYC;STAT3;ETS1;HIF1A,4062,0.050002461962676645
133,Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0048010),1.4858275840618615e-05,6/29,0.20689655172413793,26.59390407888839,394.3015985500817,FLT1;KDR;HSPB1;FYN;MAPK14;PTK2,4062,0.050002461962676645
133,Positive Regulation of miRNA Transcription (GO:1902895),1.616926336394627e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,IL10;SREBF1;TGFB1;MYC;STAT3;ETS1;HIF1A,4062,0.050002461962676645
133,Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),2.1312724541908077e-05,7/49,0.14285714285714285,17.06217616580311,246.1778312950879,IL10;PDGFRB;TGFB1;HDAC1;STAT1;MMP2;BMPR1A,4062,0.050002461962676645
133,Transforming Growth Factor Beta Receptor Signaling Pathway (GO:0007179),3.327656185645076e-05,8/76,0.10526315789473684,12.090686274509803,168.10209046640423,ACVRL1;ITGB1;GDF9;TGFB1;STAT3;APOA1;PTK2;BMPR1A,4062,0.050002461962676645
133,Regulation of Focal Adhesion Assembly (GO:0051893),3.327656185645076e-05,7/53,0.1320754716981132,15.57535480964181,216.14494720002264,ACVRL1;KDR;TEK;EFNA5;EPHA3;PTK2;S100A10,4062,0.050002461962676645
133,Positive Regulation of miRNA Metabolic Process (GO:2000630),3.327656185645076e-05,7/53,0.1320754716981132,15.57535480964181,216.14494720002264,IL10;SREBF1;TGFB1;MYC;STAT3;ETS1;HIF1A,4062,0.050002461962676645
133,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),4.168520985125677e-05,7/55,0.12727272727272726,14.924870466321243,203.26608191930924,STAT1;STAT3;LIF;STAT6;TYK2;IL6ST;JAK1,4062,0.050002461962676645
133,Positive Regulation of Interleukin-1 Beta Production (GO:0032731),4.576352843096634e-05,7/56,0.125,14.619541080680976,197.27895870167836,APP;CASP8;FZD5;STAT3;HSPB1;NLRP3;CCL19,4062,0.050002461962676645
133,Negative Regulation of Cell-Cell Adhesion (GO:0022408),7.912996550689631e-05,6/40,0.15,17.979987871437235,230.66183359791003,IL10;TGFB1;EPCAM;APOA1;BMP6;PTK2,4062,0.050002461962676645
133,Regulation of Mast Cell Degranulation (GO:0043304),8.699928102233536e-05,4/11,0.36363636363636365,57.70553935860058,733.2413213987782,FGR;LYN;CD300A;FES,4062,0.050002461962676645
133,Type I Interferon-Mediated Signaling Pathway (GO:0060337),0.00010210723445554584,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,HDAC4;IFITM3;IFI27;STAT1;TYK2;JAK1,4062,0.050002461962676645
133,Cellular Response to Type I Interferon (GO:0071357),0.0001146265884303244,6/43,0.13953488372093023,16.5196433546949,204.6962509645269,HDAC4;IFITM3;IFI27;STAT1;TYK2;JAK1,4062,0.050002461962676645
133,Detection of Calcium Ion (GO:0005513),0.00012128345520512962,4/12,0.3333333333333333,50.48979591836735,621.4783262572987,CASR;CALM3;CALM1;CALM2,4062,0.050002461962676645
133,Positive Regulation of Vascular Endothelial Growth Factor Production (GO:0010575),0.0001674581951265296,5/27,0.18518518518518517,23.05128205128205,275.60325810758144,TGFB1;STAT3;BRCA1;IL6ST;HIF1A,4062,0.050002461962676645
133,Response to UV-A (GO:0070141),0.0001674581951265296,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,CCND1;MMP1;MMP2;TIMP1,4062,0.050002461962676645
133,Regulation of Protein Modification by Small Protein Conjugation or Removal (GO:1903320),0.00019602558843395543,5/28,0.17857142857142858,22.0479375696767,259.44921421372527,HSP90AA1;HSP90AB1;CTNNB1;HIF1A;HSPA1B,4062,0.050002461962676645
133,Regulation of Vascular Endothelial Growth Factor Production (GO:0010574),0.0002291265804703249,5/29,0.1724137931034483,21.128205128205128,244.79950290336265,TGFB1;STAT3;BRCA1;IL6ST;HIF1A,4062,0.050002461962676645
133,Positive Regulation of Response to Wounding (GO:1903036),0.00026394694891091456,5/30,0.16666666666666666,20.28205128205128,231.46246946256952,ITGB1;VTN;CLDN4;ANXA1;PTK2,4062,0.050002461962676645
133,Positive Regulation of Reactive Oxygen Species Metabolic Process (GO:2000379),0.00030391293513169315,6/52,0.11538461538461539,13.281488121918422,149.54976885226935,PDGFRB;APP;TGFB1;GSTP1;MAPK14;SOD1,4062,0.050002461962676645
133,Regulation of Smooth Muscle Cell Proliferation (GO:0048660),0.0003556244598585403,6/54,0.1111111111111111,12.72680412371134,140.48713948343524,PDGFRB;TGFB1;HDAC1;STAT1;IGFBP3;CTNNB1,4062,0.050002461962676645
133,Regulation of Superoxide Anion Generation (GO:0032928),0.0003556244598585403,4/16,0.25,33.6530612244898,371.4740483715657,APP;TGFB1;GSTP1;SOD1,4062,0.050002461962676645
133,Positive Regulation of Superoxide Anion Generation (GO:0032930),0.0003556244598585403,4/16,0.25,33.6530612244898,371.4740483715657,APP;TGFB1;GSTP1;SOD1,4062,0.050002461962676645
133,Interferon-Mediated Signaling Pathway (GO:0140888),0.0003876628222768457,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,IFITM3;HDAC4;IFI27;STAT1;TYK2;JAK1,4062,0.050002461962676645
133,Detection of Muscle Stretch (GO:0035995),0.0004092846699822252,3/6,0.5,100.49238578680205,1091.0444080855816,TTR;CTNNB1;PTK2,4062,0.050002461962676645
133,Negative Regulation of Inflammatory Response to Antigenic Stimulus (GO:0002862),0.00043427259763905145,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,LYN;FGR;FYN;MAPK14,4062,0.050002461962676645
133,Sprouting Angiogenesis (GO:0002040),0.0004974968125356997,6/58,0.10344827586206896,11.745440126883423,124.76695832755246,FLT1;TGFB1;ANGPT1;KDR;RSPO3;TEK,4062,0.050002461962676645
437,Regulation of miRNA Transcription (GO:1902893),1.5742958041294077e-12,14/66,0.21212121212121213,28.58478081058726,954.946428021264,SREBF1;JUN;SMAD3;STAT3;PDGFB;FOS;NR3C1;AREG;ETS1;VEGFA;IL6;MYC;SOX9;PPARA,4062,0.050002461962676645
437,+ Reg of Phosphatidylinositol 3-Kinase/Prot Kinase B Signal Transduction (GO:0051897),1.0800866412938408e-10,17/162,0.10493827160493827,12.59223666855097,354.1916662154982,DDR1;P2RY12;BECN1;FLT1;SRC;PDGFB;PTK2;INS;VEGFA;ERBB3;GPER1;LEP;KDR;PECAM1;CCL3;IAPP;HCST,4062,0.050002461962676645
437,Positive Regulation of miRNA Transcription (GO:1902895),1.580548943896235e-10,11/47,0.23404255319148937,31.952380952380956,884.0267350671195,SREBF1;JUN;IL6;SMAD3;MYC;STAT3;PDGFB;FOS;NR3C1;AREG;ETS1,4062,0.050002461962676645
437,Positive Regulation of miRNA Metabolic Process (GO:2000630),5.690109945650924e-10,11/53,0.20754716981132076,27.379440665154952,718.5172490614301,SREBF1;JUN;IL6;SMAD3;MYC;STAT3;PDGFB;FOS;NR3C1;AREG;ETS1,4062,0.050002461962676645
437,Positive Regulation of Interleukin-1 Beta Production (GO:0032731),1.84418677864301e-08,10/56,0.17857142857142858,22.60183066361556,505.8623563053081,IL6;CASP8;FZD5;STAT3;CCL3;HSPB1;CD36;NLRC4;NLRP1;AZU1,4062,0.050002461962676645
437,Regulation of Interleukin-1 Beta Production (GO:0032651),4.8742565471450874e-08,11/82,0.13414634146341464,16.172516580967287,344.17888204774107,IL6;CASP8;FZD5;GSTP1;STAT3;CCL3;HSPB1;CD36;NLRC4;NLRP1;AZU1,4062,0.050002461962676645
437,Positive Regulation of Interleukin-1 Production (GO:0032732),5.157695145677624e-08,10/63,0.15873015873015872,19.609731876861968,415.0232274625276,IL6;CASP8;FZD5;STAT3;CCL3;HSPB1;CD36;NLRC4;NLRP1;AZU1,4062,0.050002461962676645
437,Regulation of T Cell Proliferation (GO:0042129),5.157695145677624e-08,11/83,0.13253012048192772,15.947089947089948,337.25274730743286,TNFSF18;LGALS3;IL6;ANXA1;CD40LG;LEP;CD28;TNFSF9;TYK2;TNFRSF21;IDO1,4062,0.050002461962676645
437,Cell Surface Receptor Signaling Pathway via STAT (GO:0097696),2.4513657500810685e-07,9/55,0.16363636363636364,20.235146824493512,393.6007286626139,IL6;TSLP;LEP;STAT3;LIF;STAT6;TYK2;JAK1;TNFRSF1A,4062,0.050002461962676645
437,Peptidyl-Tyrosine Phosphorylation (GO:0018108),3.8757133660864203e-07,9/58,0.15517241379310345,18.99337536061545,360.14302491616854,DDR1;LYN;FLT1;SYK;SRC;KDR;PDGFB;ABL1;PTK2,4062,0.050002461962676645
437,Ephrin Receptor Signaling Pathway (GO:0048013),5.681861190997971e-07,8/43,0.18604651162790697,23.529761904761905,435.0499090286752,LYN;EFNA1;SRC;MMP2;EFNA4;EPHB4;PTK2;EPHB3,4062,0.050002461962676645
437,Peptidyl-Tyrosine Modification (GO:0018212),9.473510647463356e-07,8/46,0.17391304347826086,21.66885964912281,388.4690218387859,LYN;FLT1;SYK;SRC;PDGFB;ABL1;KDR;PTK2,4062,0.050002461962676645
437,Regulation of Extrinsic Apoptotic Signaling Pathway (GO:2001236),9.473510647463356e-07,9/65,0.13846153846153847,16.613313388182497,297.7530303415938,ACVR1;LGALS3;CD40LG;SRC;GPER1;GSTP1;CFLAR;LTBR;AREG,4062,0.050002461962676645
437,Growth Hormone Receptor Signaling Pathway via JAK-STAT (GO:0060397),1.289902682114038e-06,5/10,0.5,101.51282051282053,1785.329817856251,LYN;STAT3;STAT6;TYK2;JAK1,4062,0.050002461962676645
437,Extrinsic Apoptotic Signaling Pathway (GO:0097191),1.3502109697007668e-06,9/68,0.1323529411764706,15.76617268613009,276.15342747426,CASP8;SMAD3;IFI27;ERBB3;BAG3;TNFRSF10B;TNFRSF10A;CFLAR;TNFRSF1A,4062,0.050002461962676645
437,Growth Hormone Receptor Signaling Pathway (GO:0060396),2.2525684659061543e-06,6/21,0.2857142857142857,40.79381443298969,690.6248819207933,LYN;STAT3;STAT6;TYK2;PTK2;JAK1,4062,0.050002461962676645
437,Aortic Valve Development (GO:0003176),7.181930196790229e-06,7/41,0.17073170731707318,21.085339835416036,331.06423432395894,EFNA1;NOTCH1;JAG1;TIE1;SNAI1;SOX9;TNFRSF1A,4062,0.050002461962676645
437,Regulation of Microglial Cell Activation (GO:1903978),1.1683546310418068e-05,5/15,0.3333333333333333,50.74358974358975,768.7656511195227,IL6;CCL3;CST7;MMP8;LDLR,4062,0.050002461962676645
437,Regulation of Interleukin-10 Production (GO:0032653),1.4752057785846472e-05,7/46,0.15217391304347827,18.377441211638104,273.3824888472053,IL6;CD40LG;SYK;TSLP;STAT3;CD28;TNFRSF21,4062,0.050002461962676645
437,Vascular Endothelial Growth Factor Receptor Signaling Pathway (GO:0048010),1.519241010401128e-05,6/29,0.20689655172413793,26.59390407888839,394.3015985500817,FLT1;SRC;KDR;HSPB1;PTK2;VEGFA,4062,0.050002461962676645
437,Cell Surface Receptor Signaling Pathway via JAK-STAT (GO:0007259),1.5914662596393023e-05,7/47,0.14893617021276595,17.917098445595855,263.7963592880561,IL6;TSLP;STAT3;STAT6;TYK2;JAK1;TNFRSF1A,4062,0.050002461962676645
437,Positive Regulation of Interleukin-10 Production (GO:0032733),1.746343579326592e-05,6/30,0.2,25.484536082474225,372.378647731317,IL6;CD40LG;SYK;TSLP;STAT3;CD28,4062,0.050002461962676645
437,Regulation of Cell Adhesion Mediated by Integrin (GO:0033628),2.9617477006795297e-05,6/33,0.18181818181818182,22.649484536082475,317.3982287063927,LYN;P2RY12;EFNA1;SYK;LIF;PTK2,4062,0.050002461962676645
437,Cellular Response to Mechanical Stimulus (GO:0071260),3.3010499550131395e-05,7/53,0.1320754716981132,15.57535480964181,216.14494720002264,CASP8;PECAM1;TNFRSF10B;TNFRSF10A;SOX9;LTBR;TNFRSF1A,4062,0.050002461962676645
437,Cell Chemotaxis (GO:0060326),3.846181979253088e-05,8/78,0.10256410256410256,11.74404761904762,160.9238386488789,CCRL2;XCL2;CXCR5;PDGFB;CCL3;AZU1;CCR5;VEGFA,4062,0.050002461962676645
437,Regulation of Erythrocyte Differentiation (GO:0045646),5.968827297489898e-05,6/38,0.15789473684210525,19.105670103092784,251.0820739334879,LYN;ZFP36;STAT3;ETS1;ACVR2A;HSPA1A,4062,0.050002461962676645
437,Aortic Valve Morphogenesis (GO:0003180),5.968827297489898e-05,6/38,0.15789473684210525,19.105670103092784,251.0820739334879,EFNA1;NOTCH1;JAG1;TIE1;SNAI1;SOX9,4062,0.050002461962676645
437,Monocyte Chemotaxis (GO:0002548),7.850691584307928e-05,5/23,0.21739130434782608,28.17948717948718,360.6611683989916,LGALS3;IL6;FLT1;PDGFB;CCL3,4062,0.050002461962676645
437,Placenta Development (GO:0001890),7.850691584307928e-05,5/23,0.21739130434782608,28.17948717948718,360.6611683989916,LEP;PDGFB;TFEB;PHLDA2;PTK2,4062,0.050002461962676645
437,Cellular Response to Steroid Hormone Stimulus (GO:0071383),9.373290820721396e-05,5/24,0.20833333333333334,26.695006747638327,335.64237766536246,SRC;GPER1;NR3C1;AREG;HSPA1A,4062,0.050002461962676645
437,Blood Vessel Diameter Maintenance (GO:0097746),9.481080830644165e-05,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,NPPB;ACE2;SRC;GPER1;PECAM1;INS,4062,0.050002461962676645
437,Positive Regulation of Receptor Signaling Pathway via STAT (GO:1904894),9.481080830644165e-05,6/42,0.14285714285714285,16.97938144329897,212.80352569829228,IL6;NOTCH1;TSLP;LEP;LIF;TYK2,4062,0.050002461962676645
437,Positive Regulation of T Cell Proliferation (GO:0042102),9.966127402414296e-05,7/65,0.1076923076923077,12.345363587636234,153.9576885075937,IL6;ANXA1;CD40LG;LEP;CD28;TNFSF9;TYK2,4062,0.050002461962676645
437,Negative Regulation of miRNA Transcription (GO:1902894),0.00011020436424365194,5/25,0.2,25.35897435897436,313.3915485176811,SMAD3;PDGFB;SOX9;PPARA;VEGFA,4062,0.050002461962676645
437,Interleukin-6-Mediated Signaling Pathway (GO:0070102),0.0001143864171787685,4/12,0.3333333333333333,50.48979591836735,621.4783262572987,IL6;SRC;STAT3;JAK1,4062,0.050002461962676645
437,Positive Regulation of Chemotaxis (GO:0050921),0.00015423938080450986,6/46,0.13043478260869565,15.278350515463918,183.1344786743041,P2RY12;IL6;PDGFB;KDR;HSPB1;VEGFA,4062,0.050002461962676645
437,Negative Regulation of miRNA Metabolic Process (GO:2000629),0.00015648138354305586,5/27,0.18518518518518517,23.05128205128205,275.60325810758144,SMAD3;PDGFB;SOX9;PPARA;VEGFA,4062,0.050002461962676645
437,Cardiac Cell Development (GO:0055006),0.00015648138354305586,4/13,0.3076923076923077,44.87755102040816,536.2469711319385,JAG1;NOTCH1;MYH11;VEGFA,4062,0.050002461962676645
437,Positive Regulation of Epithelial to Mesenchymal Transition (GO:0010718),0.0002076952484974755,6/49,0.12244897959183673,14.210261328218651,164.99131524160097,IL6;NOTCH1;JAG1;SMAD3;SNAI1;PTK2,4062,0.050002461962676645
437,Positive Regulation of Smooth Muscle Cell Proliferation (GO:0048661),0.0002076952484974755,6/49,0.12244897959183673,14.210261328218651,164.99131524160097,JUN;IL6;FGF9;HDAC1;MMP2;PDGFB,4062,0.050002461962676645
437,Positive Regulation of Blood Vessel Endothelial Cell Migration (GO:0043536),0.0002244141230039781,6/50,0.12,13.88659793814433,159.57344828850043,ANXA1;KDR;PDGFB;HSPB1;ETS1;VEGFA,4062,0.050002461962676645
437,Extrinsic Apoptotic Signaling Pathway via Death Domain Receptors (GO:0008625),0.00030712074746652284,5/32,0.15625,18.77777777777778,208.10711759419505,CASP8;TNFRSF10B;TNFRSF10A;CFLAR;TNFRSF1A,4062,0.050002461962676645
437,Nuclear Receptor-Mediated Signaling Pathway (GO:0141193),0.00030712074746652284,5/32,0.15625,18.77777777777778,208.10711759419505,RXRB;GPER1;NR3C1;PPARA;AREG,4062,0.050002461962676645
437,Cellular Response to Corticosteroid Stimulus (GO:0071384),0.0003170035988695086,4/16,0.25,33.6530612244898,371.4740483715657,ZFP36;ANXA1;GPER1;NR3C1,4062,0.050002461962676645
437,Regulation of Cytokine Production Involved in Inflammatory Response (GO:1900015),0.0003463479606320355,6/55,0.10909090909090909,12.466442247001892,136.27645857990532,ZFP36;IL6;LEP;STAT3;PPARA;IL17D,4062,0.050002461962676645
437,Response to Peptide Hormone (GO:0043434),0.0003712074269645193,6/56,0.10714285714285714,12.216494845360824,132.26100624841683,SMAD3;SRC;GPER1;LEP;STAT3;STAT6,4062,0.050002461962676645
437,Regulation of Endothelial Cell Chemotaxis (GO:2001026),0.0003862689943628114,4/17,0.23529411764705882,31.06279434850864,334.7923648041761,NOTCH1;KDR;HSPB1;VEGFA,4062,0.050002461962676645
437,Heart Morphogenesis (GO:0003007),0.0004043587867873476,6/57,0.10526315789473684,11.97634930260764,128.42832253074832,ACVR1;NOTCH1;SOX9;EPHB4;PTK2;VEGFA,4062,0.050002461962676645
437,Regulation of Lymphocyte Proliferation (GO:0050670),0.0004749048287225971,4/18,0.2222222222222222,28.84256559766764,303.8404891137544,TNFSF18;LGALS3;LEP;TNFSF9,4062,0.050002461962676645
437,Regulation of Acute Inflammatory Response (GO:0002673),0.0004749048287225971,4/18,0.2222222222222222,28.84256559766764,303.8404891137544,IL6;GSTP1;OSMR;INS,4062,0.050002461962676645
437,Cellular Response to Vascular Endothelial Growth Factor Stimulus (GO:0035924),0.0004905706153887033,5/36,0.1388888888888889,16.351530190239867,171.49530707153963,FLT1;NOTCH1;KDR;HSPB1;VEGFA,4062,0.050002461962676645
